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Abstract  
Introduction: Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder 
characterised by deficits in social communication and restricted behaviours, and associated 
with sensory alterations, gastrointestinal dysfunction and disruptions in the circadian rhythm. 
This study utilised two animal models of ASD, the BTBR T+tf/J and the prenatal exposure to 
VPA mouse models of ASD, compared to the control C57 BL/6J strain. The aim of this study 
was to investigate changes in circadian rhythm and peripheral sensation in the two mouse 
models of ASD, and identify potential pathways involved.   
Methods: Home-cage testing was conducted using LABORAS platforms, to record the 
animals’ behaviour over 24 hours (C57 n = 8; BTBR = 9, VPA = 4). Cutaneous sensory 
thresholds were determined using the dynamic hot (DHP) and cold plate (DCP) tests (C57 n 
= 6; BTBR n = 6; VPA n = 4), and sensory function of the gastrointestinal tract was outlined 
using ex-vivo jejunum preparations, by recording the afferent nerve responses to mechanical 
and chemical stimuli. Values are mean +/- SEM analysed with two-way ANOVA using 
GraphPad Prism.  
Results: the VPA mice exhibited altered circadian rhythm in the dark (active) phase compared 
to the BTBR and C57 mice (P=<0.05). In the DHP, the BTBR mice (n = 6) responded at a 
higher temperature (C57 - 38C; BTBR - 40C), responded significantly less to heat (P<0.0005), 
while VPA mice (n = 4) showed similar responses to the C57 mice. In the DCP, VPA mice start 
to respond at a lower temperature (C57 - 16C; VPA - 2C), responded slightly less to cold 
(P=0.055), while the BTBR mice showed similar responses to C57 mice.  
In the afferent nerve recordings of the jejunum, the BTBR tissue exhibited significantly 
decreased responses to mechanical distension at a filling rate of 600 µl/min (P<0.0006; BTBR 
n = 9; C57 n = 10). Peak firing rate at 50 mmHg was 92.68 (+/- 12.80) imp/s-1 in recordings 
from C57 (n = 10) tissue and 76.49 (+/- 15.44) imp/s-1 in BTBR tissue (n = 9). BTBR afferents 
also showed an altered response profile to TRPV1 activation (P=<0.0001, BTBR n = 5; C57 n 
= 5), whereby nerve firing took significantly longer to desensitize compared to control afferents, 
suggesting altered function of TRPV1. Preparations from BTBR mice also exhibited 
significantly increased response to intraluminal application of an inflammatory soup (P<0.05), 
BTBR n = 5; C57 n = 5).   
Conclusion: the VPA model of ASD showed marked alterations in circadian rhythm and 
reduced response to cold stimuli, and the BTBR mouse model of ASD exhibited significantly 
decreased response to heat and significantly altered afferent nerve activity from the jejunum 
in response to various stimuli. Future studies should investigate whether these changes 
correlate with CNS dysfunction or whether altered peripheral sensation could drive some of 
the central deficits observed in ASD.  
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Glossary of terms and abbreviations  
  
ASD  Autism Spectrum 
Disorder  
DRG  Dorsal root ganglion  
DSM - 5  Diagnostic and  
Statistical Manual of  
Mental Disorders  
Volume 5  
IPAN  Intrinsic primary 
afferent neuron  
ICD  International  
Classification of 
Diseases  
DEC/ENaC  Degenerin/epithelial 
sodium channel  
GABA    
γ-aminobutyric acid  
ASIC  Acid sensing ion 
channel  
BTBR  BTBR T+ tf/J 
(BTBR) an inbred 
mouse strain  
5-HT  5-hydroxytryptamine  
BDNF  Brain derived 
neurotrophic factor  
5-HT3  5-hydroxytryptamine 
receptor 3  
GI   Gastrointestinal   NGF  Nerve growth factor  
VPA  Valproic acid  PGE2  Prostaglandin E2  
SAL  Saline   ATP  Adenosine 
triphosphate  
mGluR  Metabotropic 
glutamate receptor  
SEM  Standard error of the 
mean  
SCN  Suprachiasmatic 
nucleus  
ENS  Enteric nervous 
system  
ASMT  Acetylserotonin 
Omethyltransferase  
NTS  Nucleus tractus 
solitarius  
TRP  Transient receptor 
protein  
IBS  Irritable bowel 
syndrome  
DHP  Dynamic hot plate  DCP  Dynamic cold plate  
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1 Introduction  
1.1 What is ASD?  
  
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterised by deficits 
in social communication and repetitive, restricted behaviours (American Psychiatric 
Association, 2013). ASD is one of the most heritable conditions of all the most complex 
neurodevelopmental disorders (Constantino, 2013), however, diagnosis is based on 
behavioural symptoms. The gold standards for diagnosis of mental disorders such as ASD are 
the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) and the International 
Classification of Diseases (ICD). Both manuals have classified Autism as a spectrum in their 
updates, incorporating all the subcategories in the previous versions. This allows all the 
different presentations of ASD to be considered in a more holistic view (Hayes, 2018).  
  
Less than 1% of ASD cases have been confirmed to have a genetic basis (Chaste, 2015) and 
decades of studies on interactions of gene variants in the aetiology of ASD to predict risk of 
the condition have been unsuccessful. There is substantial genetic variability in ASD, which 
could cause the phenotypic heterogeneity characterising the spectrum (Asif, 2019). There has 
been a lot of effort to find biomarkers for diagnosis and personalising treatment, however this 
has been difficult due to the complexity of ASD (Klin, 2018).   
  
One of the most prominent theories developed to explain brain abnormalities leading to ASD 
is alterations in connectivity, many groups have shown altered brain connectivity (Just, 2007; 
Kana, 2006, Villalobos, 2005; Kleinhans, 2008). Functional magnetic resonance imaging 
(fMRI) studies have shown abnormalities in the structure of brain regions such as the 
amygdala, cingulated anterior cortex and the cerebellum (Uddin, 2009). This altered 
connectivity impacts excitation-inhibition balances in ASD, Hegarty et al found altered cerebro-
cellebellar functional connectivity was associated with cerebellar excitation-inhibition 
imbalances in individuals with ASD but not controls (Hegarty, 2018) which may suggest 
alteration in neurotransmitter levels. Neurotransmitters associated most commonly with ASD 
are the GABAergic, glutamatergic and serotonergic systems (Trottier, 1999).  
  
ASD is almost 2-3 times more prevalent in males than females (Kim, 2011), however this may 
be due to difference in presentation which may explain why adult females with autistic disorder 
were diagnosed later in life (Begeer, 2013). ASD develops before children reach the age of 3, 
in some cases development is normal until the child ‘regresses’, by slowly losing language 
and refusing to make eye contact. This occurs in around 30% of cases (Parr, 2011).  
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The pathophysiology and aetiology of ASD is still not known, however, research has shown it 
is a multi-factorial disorder due to the variety of genes and environmental factors that 
contribute to its pathogenesis (Yenkoyan, 2017).   
  
1.2 Animal models of ASD  
  
To study the physiological manifestations of ASD, preclinical animal models have been 
developed (Erdogan, 2017). These models are based on laboratory rodents, as they are social 
animals, and any deficits in sociability can be detected easily (Cryan, 2005). Tests of rodent 
sociability include contact with known or unknown animals of the same species, social 
interaction, ultrasonic vocalisations (rodents vocalise below the frequency of human hearing) 
and aggressive behaviour (Grant, 1963; Carter, 1992; Terranova, 2005). Behavioural 
phenotyping of ASD models is based on the three domains affected in human ASDs, repetitive 
behaviour, communication and sociability.   
  
To be considered a relevant model of human psychiatric disorders, animal models must fit pre-
determined criteria, or validities. These are the construct, face and predictive validities 
(Willner, 1986). Construct validity is based on the causation of the studied phenotype, human 
ASDs are associated with genetic and environmental factors, so an animal model should be 
built using these factors (Belzung, 2005). If the animal model exhibits the same phenotypes 
or symptoms as the human disorder, it satisfies face validity. In this context, the animal model 
must show the behavioural diagnostic features of ASD, socio-communication deficits and 
repetitive restricted behaviours (Mabunga, 2015). Predictive validity means that any 
interventions to treat the symptoms in the human disorder should do the same in the animal 
model (Willner, 1986).  
  
To generate these models, researchers replicate the genetic and environmental alterations 
that have been associated with development of ASD, such as knock out or humanised knock 
in of gene mutations and copy number variations reported in ASD such as fragile X syndrome 
and tuberous sclerosis (Gross, 2015; Baudouin, 2012). Other ASD-associated genetic 
alterations can occur spontaneously in some strains of mice such as the BTBR T+tf/J mice 
(McFarlane, 2008). Animal models of ASD can be induced through in utero exposure to 
various conditions associated with human ASD such as valproic acid (VPA) (Christensen, 
2013). 
  
BTBR T+tf/J (BTBR)   
BTBR mice are an inbred strain, originally bred for studies on insulin resistance and 
phenylketonuria, it was discovered that these mice display consistent ASD-relevant 
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behaviours including increased repetitive grooming and deficits in sociability and 
communication (Bolivar, 2007; Moy, 2006; Nadler, 2006). Daimon et al conducted 
transcriptomic and proteomic analyses on hippocampal tissue of BTBR mice, finding reduced 
expression of brain derived neurotrophic factor (BDNF), Caskin1 and HOMER31 (Daimon, 
2015), which have also been reported human ASD (Sheikh, 2010; Abrahams, 2008). These 
mice exhibit reduced size or complete destruction of the corpus callosum, a large bundle of 
nerve fibres that connect the two hemispheres of the brain which has been implicated in ASD, 
however the causal relationship is not clear (Paul, 2014). BTBR mice show gastrointestinal 
disruptions, altered GI motility and permeability, possibly due to disruptions in the serotonergic 
system (Golubeva, 2017).  
  
The BTBR strain thus exhibits construct and face validity as a model of ASD, in order to 
determine whether it displays predictive validity, researchers conducted pharmacological 
intervention to improve the ASD-like symptoms. Silverman et al aimed to manipulate the 
excitatory neurotransmission of BTBR mice by administering methyl-6-phenylethynyl-pyridine 
(MPEP), an antagonist of the metabotropic glutamate receptor 5 (mGluR5). They reported 
MPEP significantly reduced repetitive self-grooming in the BTBR mice (Silverman, 2010). 
Berry-Kravis et al used another mGluR5 antagonist, fenobam, to treat adults with Fragile X 
syndrome, they found an improvement of 20% in the pre-pulse inhibition test, which measures 
acoustic sensory gating (Berry-Kravis, 2009)  
  
Prenatal exposure to valproic acid (VPA)  
Exposure to certain pharmacological agents in utero increases the risk of ASD, valproic acid 
(VPA) is an anti-epileptic drug and causes teratogenicity and neural tube defects (Choi, 2016). 
The prenatal VPA model of ASD is believed to be a better representation of autism caused by 
environmental and epigenetic causes (Nicolini, 2018) and shows good construct, face and 
predictive validity (Mabunga, 2015). VPA rodents exhibit alterations in sensory processing, 
Dendrinos et al reported alterations in development of the superior colliculus, a brain region 
essential for multisensory information processing (Dendrinos, 2011). Gastrointestinal 
alterations have also been reported in the VPA model of ASD, Kim et al found significant 
changes in the thickness of the mucosa and muscle layers of the stomach and ileum, abnormal 
epithelial cell morphology and impaired GI motility (Kim, 2013).    
Use of VPA by pregnant women in the first trimester led to an increased risk of ASD 
(Christensen, 2013), and exposure to VPA on pregnant mice on embryonic day 11-12 results 
in increased stereotypic behaviour (Schneider, 2008) and decreased social interaction  
(Lucchina, 2014). Campolongo et al conducted a study comparing impact of housing in 
sociability of VPA mice, by housing VPA treated mice with saline treated mice (VPA-SAL) and 
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VPA mice with other VPA mice (VPA-VPA), with SAL-SAL as control. Their rationale was that 
housing VPA mice with other VPA mice contributed to reduced social interaction, and housing 
with control mice could act as a social enrichment exercise. Their results showed increased 
social interaction and play between VPA-VPA and VPA-SAL mice, however, repetitive and 
depression-like behaviours were not altered (Campolongo, 2010). Social enrichment has been 
reported to improve ASD symptoms in humans (Woo, 2013; Woo, 2015). MGluR5 antagonists 
have also been used to improve stereotypical behaviours in prenatal VPA mice (Mehta, 2011).   
1.3 Co-morbidities in ASD  
Many medical conditions appear to have higher prevalence in individuals in ASD compared to 
neuro-typical individuals, including epilepsy (Woolfenden, 2009), hypertension (Croen, 2015) 
and gastrointestinal dysfunction (Kohane, 2012). There is also increased rates of sleep 
problems in ASD, reports range between 50-80% (Richdale, 2009). Individuals with ASD are 
prescribed multiple psychotropic medications (Esbensen, 2009) which increase morbidity and 
disrupt healthy ageing (Bishop-Fitzpatrick, 2018).  
  
Certain behaviours such as aggression and head banging have been considered part of the 
symptomology of ASD, however, may be a manifestation of untreated symptoms from other 
diseases, including gastrointestinal disorders (Buie, 2010). These reports support the theory 
that ASD is a whole-body disorder, and research is increasingly branching out into numerous 
biomedical fields. The focus of this study is to delineate the impact of circadian rhythm 
alterations and sensory disruption in the somatic and visceral transduction pathways in mouse 
models of ASD.  
  
Circadian alterations in ASD  
Children and adults with ASD exhibit increased sleep difficulty and altered circadian sleep 
rhythmicity compared to the general population (Carmassi, 2019). Studies have shown 
children with ASD may show sleeplessness defined by phase delay of sleep periods, and 
irregular sleep-wake patterns, Giannotti et al reported children with regressive ASD showed 
higher sleep onset delay, sleep duration and night awakening scores (Giannotti, 2008). The 
prenatal VPA animal model of ASD shows altered circadian rhythm, characterised by 
increased arousal in the sleep phase (Tsujino, 2007; Cusmano, 2014). Loohuis et al reported 
differential expression of genes involved in circadian regulation in VPA rats (Loohuis, 2017).  
  
The suprachiasmatic nucleus (SCN) is the master biological clock of the hypothalamus  
(Moore, 1972; Stephan, 1972) and its neurons contain autonomous transcription-based 
clockwork (Kornhauser, 1996). It is controlled by the light-dark cycle, which is detected by the 
rod and cone cells in the retina, relaying the information to the SCN via a monosynaptic 
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pathway (Weng, 2009). Light also affects CLOCK genes which have approximately 24-hour 
gene transcription rhythms (Kornhauser, 1996), they are expressed in cells within bodily 
tissues and form translation/transcription negative feedback loops (Potter, 2016). Production 
of melatonin regulates the peripheral clock in a feed-forward mechanism (Meissl, 1990).   
  
Altered circadian rhythm in ASD has been hypothesised to be due to polymorphisms in  
CLOCK genes (Yang, 2016) and genes involved in the production of melatonin (Jonsson,  
2010). There has been a consistent finding of reduction in peripheral melatonin concentrations 
(Tordjman, 2005; Tordjman, 2012), potentially due to reduced activity of acetyl-serotonin 
Omethyltransferase (ASMT), an enzyme in the biosynthetic pathway from serotonin to 
melatonin (Melke, 2008). Reduced activity of ASMT could provide an explanation for the high 
peripheral serotonin and low melatonin concentrations observed in ASD (Missig, 2019).   
  
To assess the circadian rhythm of the mouse models of ASD, we employed LABORAS 
(Laboratory Animal Behaviour Observation Registration and Analysis System), which is an 
automated system used for recognition of behaviours exhibited by mice and rats. It includes a 
platform, with a cage placed on top with bedding and food and water. By measuring the forces 
produced by the animal’s movement on the platform, it scores behaviours such as grooming, 
locomotion, average speed, maximum speed and distance travelled (Van de Weerd, 2001). 
By recording the control C57, BTBR and prenatal VPA mice for 24 hours, we can observe their 
sleep-wake cycle and activity. The software also records eating behaviour, which could 
provide evidence for any differences in feeding exhibited by the mouse models of ASD, as 
altered feeding behaviour has been reported in ASD (Castro, 2016). This technique has been 
used previously by Pitzer et al, who conducted longitudinal home cage monitoring in their 
animal model of inflammatory pain (Pitzer, 2016).   
  
Sensory disruption in ASD  
Over 90% of individuals with ASD have atypical sensory processing (Chang, 2014) in all 
sensory modalities. Alterations in sensory processing have been described in literature 
reporting autism symptomology (Adrien et al., 1987, 1992, 1993; Baranek, 1999; Dahlgren & 
Gillberg, 1989; Kientz & Dunn, 1997; Ornitz, 1989; Ornitz et al., 1993) as well as by individuals 
with ASD themselves (Grandin, 1995).  Sensory disruption in ASD can take three main forms, 
sensory hypo-responsiveness, hyper-responsiveness and sensory seeking, a behaviour 
characterised by a craving for a certain sensory experience (Hazen, 2014) and many 
individuals have a combination of the three.   
  
Abnormalities in the processing and integration of sensory information can disrupt 
development intellectually and socially, for example, children with altered sensory processing 
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show delays in development of fine and gross motor skills, lack of coordination and poor 
balance (DeGangi, 1989). Disruption in auditory processing are of the more commonly 
reported sensory impairments in ASD, Greenspan et al found 100% of their participants (200 
individuals) exhibited difficulties in responding to auditory stimuli (Greenspan, 1997). 
Avoidance of eye contact and gaze is a hallmark feature of ASD (Senju, 2009) and 
hypersensitivity to tactile stimuli has been associated with increased repetitive behaviours and 
verbalization, as well as abnormal attention focus (Baranek, 1997).  
  
ASD has been associated with an indifference or hyposensitivity to pain stimuli, Nader et al 
compared responses to venepuncture in typically developing and ASD children, they found 
the children with ASD showed a delayed facial pain reaction in response to the procedure 
(Nader, 2004). They also reported discrepancies between parental reports of pain and the 
children’s responses, putting into question the use of parental questionnaires in studies of 
autism (Nader, 2004).   
  
Altered responses to thermal nociception have been reported in individuals with ASD (Cascio, 
2008; Duerden, 2015) and in animal models of ASD, Schneider et al found increased response 
latency in the tail-flick test and paw withdrawal test by rats prenatally exposed to VPA, 
concluding they have increased nociceptive threshold (Schneider, 2001). These results were 
validated by further studies in prenatal VPA mice and rats (Dendrinos, 2011; Morakotsriwan, 
2016; Mahmood, 2018). BTBR mice have also been found to display hypo-responsiveness to 
thermal stimuli (Wang, 2016) with an increased latency of paw withdrawal.    
The sensation of temperature is mediated by the polymodal transient receptor potential (TRP) 
ion channels, which are expressed on sensory primary afferent neurons (Vriens, 2014). Their 
activation thresholds encompass the temperature ranges found in the environment (Bokiniec, 
2018). There are four TRP channels that are activated by increasing temperatures, TRPV3 
(>34 –38°) and TRPV4 (> 27–35°C) mediate warm sensation, while TRPV1 (>43°C) and 
TRPV2 (>52°C) respond to hot stimuli, transducing painful sensations (Patapoutian, 2003; 
Tominaga, 2004; Dhaka, 2006). TRPM8 (<25 °C) and TRPA1 (<18 °C) mediate cold sensation 
(Peier, 2002; Bandell, 2004; Dhaka, 2006). TRPM8 knock out mice show deficits in cold 
sensitivity (Bautista, 2007; Dhaka, 2007; Colburn, 2007). The cell bodies of primary afferent 
neurons in the skin are in the dorsal root and trigeminal ganglia. The afferent nerves 
responsive to thermal stimuli are split into two types, the thinly myelinated Aδ fibres and the 
unmyelinated C fibres (Bokiniec, 2018). Figure 1.1 below shows the neural pathway of thermal 
sensing in the mouse, from the primary afferents in the skin to the spinal cord and thalamus, 
primary somatosensory cortex (S1), secondary somatosensory cortex (S2) and the insular 
cortex (IC).  
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Figure 1.1: a schematic representation of  the neural pathways transducing thermal sensation f rom paw 
to somatosensory cortex in mice. A) A diagram of  a mouse showing the thermal pathway f rom the paw 
to the brain, B) cross sections of  the murine nervous system, the numbers correspond to the points 
shown in A). Adapted f rom Bokiniec et al (2018).   
  
Han et al conducted a study investigating the role of TRPV1 in ASD thermosensation, SHANK3 
is part of a family of proteins responsible for synaptic scaffolding (Sheng, 2000), and mutations 
are found in around 2% of human ASDs (Leblon, 2014; Yi, 2016). Using different lines of 
SHANK3 mutant mice, they showed SHANK3 plays an important role in pain transduction as 
it regulates the expression of TRPV1, haploinsufficiency of SHANK3 leads to defects in 
function of TRPV1 in mouse and human dorsal root ganglion (DRG) neurons (Han, 2016). In 
the present study, we aimed to characterise the function of TRPV1 in two other mouse models 
of ASD, to determine any changes in function and to compare the somatic and visceral 
transduction pathways of pain.   
  
Thermosensation studies in mouse models of ASD have been conducted on hot plates set at 
a nociceptive temperature, where the time for the animal to withdraw their paw is measured in 
order to identify presence of hyperalgesia. However, the possibility of thermal allodynia has 
not been investigated yet. According to Yalcin et al, this can be done through use of the 
Dynamic Hot Plate (DHP) or Dynamic Cold Plate (DCP) tests, where the animal is placed on 
the plate set at an innocuous temperature, then raised or lowered slowly until nociceptive 
temperatures are reached (Yalcin, 2009). The point at which the animal starts exhibit escape 
behaviour, defined as jumping, is used as a measure of response to nociceptive temperatures. 
Thus, if the animal starts jumping at temperatures that are considered innocuous, they may 
have thermal allodynia. This test allows a bigger picture of thermal sensitivity in rodents to be 
drawn, especially in models of ASD, where sensory disruption is reported widely. In this study 
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especially, by studying visceral sensory pathways of pain through recording of gastrointestinal 
afferents, a comparison can be made between somatic and visceral pain responses in ASD.   
  
  
   
 
  
Stimulus intensity  
Figure 1.2: a graphical representation of  the relationship between stimulus intensity and pain intensity, 
in normal pain and two types of  hypersensitivity, allodynia and hyperalgesia (adapted f rom Lolignier, 
2014)  
  
Gastrointestinal disruptions in ASD  
Over the past few decades, an increase in anecdotal reports of GI disturbances in individuals 
with ASD has sparked much research interest. The most commonly reported symptoms of GI 
disruption are chronic constipation, diarrhoea and abdominal pain (Hsiao, 2014). A 2014 meta-
analysis of gastrointestinal symptoms in individuals with ASD showed an overall higher 
prevalence than neurotypical individuals, higher rates of diarrhoea, constipation and 
abdominal pain (McElhanon, 2014). They also highlighted the disparity in methodology and 
sample sizes, and how very few studies investigated the actual pathophysiology of GI 
disruption in ASD.   
  
Children with ASD who exhibit GI symptoms are often undiagnosed, reports of altered bowel 
habits are unreliable generally, and considered more so when the population has 
communication deficits (Mayer, 2014). Autism and functional GI disorders have similar 
imaging abnormalities in the brain regions regulating sensory stimuli and emotions (Ellingson, 
2013; Green, 2013). Children with irritable bowel syndrome (IBS) and functional abdominal 
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pain (FAP) show increased intestinal permeability (Shulman, 2008), in ASD this was first 
reported by de Magistris et al, who found increased permeability in 37% of patients with ASD 
and 21% of their relatives (de Magistris, 2010)  
  
Visceral hypersensitivity is the ‘enhanced intestinal perception converting otherwise 
physiologic stimuli into discomfort’ (Barshop, 2016). ASD has been linked to functional 
abdominal pain (FAP), abdominal pain without other clinical signs such as abnormal laboratory 
tests (Wasilewska, 2015). However, there have been no studies on the state of visceral 
sensitivity in ASD, even though increased abdominal pain is a commonly reported symptom. 
To measure the afferent sensory response to distension, we used an in vitro multi-unit afferent 
nerve recording technique, which has been extensively used in the literature (Rong, 2004; 
Keating, 2008; Rong, 2008; Wang, 2012; Daly, 2011)  
  
1.4 Neuroanatomy of the gut  
The autonomic nervous system controls the function of the GI tract motility and secretion. It is 
split into two main branches, the enteric nervous system (ENS) and the extrinsic neural 
elements that form the connections between the gut, brain and spinal cord (Grundy, 2008).  
  
The ENS is a complex independent nervous system comprised of the myenteric and 
submucosal plexuses that regulate reflex contractions and relaxations of the gut, as well as 
sensing the chemical contents of the lumen and controlling secretion and blood flow 
(Chandrasekharan, 2013).    
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Figure 1.3: a schematic representation of  the intrinsic and extrinsic af ferent innervation of  the small 
intestine, which extend into the lamina propria. Extrinsic vagal af ferents synapse at the nodose ganglion 
and further into the NTS, spinal af ferents synapse at the DRG and travel into the spinal cord. Intrinsic  
AH (af ter-hyperpolarisation) neurons f rom the submucosal and myenteric plexuses. There are also S  
(synapse) neurons which are mechanosensitive in the myenteric plexus, they don’t project into the 
mucosa (Furness, 1998).  
  
Extrinsic innervation of the gut comes in the forms of vagal and spinal afferent fibres. The cell 
bodies of vagal afferents are in the nodose and intracranial jugular ganglia, innervating from 
the pharynx to the proximal colon (Berthoud & Neuhuber, 2000). Spinal afferent cell bodies 
are in the dorsal root ganglia (DRG) to the spinal cord (Sengupta and Gebhart, 1994), they 
are composed of splanchnic and pelvic nerves, which follow the sympathetic and 
parasympathetic pathways to the gut wall (Grundy, 2006).  These afferent fibres innervate the 
gut wall at various levels including the muscle, mucosa and the enteric ganglia (Blackshaw, 
2007) and are near the intrinsic primary afferent neurons (IPANs) of the ENS. Extrinsic nerves 
run in mixed nerve fibres containing both afferent and efferent nerves (Sengupta and Gebhart, 
1994). The nerve terminals of vagal and spinal afferents are localised to various layers within 
the gastrointestinal tracts. In the mucosal layers and the smooth muscle, as well as the serosal 
and mesenteric attachments, and the response profile is consistent with the placement 
(Berthoud, 2000). Vagal afferents innervate mainly the upper gastrointestinal tract, and 
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regulate gastric reflexes and perception of hunger, fullness, bloating, and nausea (Vermeulen, 
2014), whereas spinal afferents mediate primarily pain signalling from the gut (Kyloh, 2011). 
  
  
Figure 1.4: a schematic representation of  extrinsic af ferent innervation to the gastrointestinal tract. On 
the lef t are the sensory nerves associated with the sympathetic nervous system. The spinal visceral 
nerve f ibres pass through prevertebral (CG – coeliac ganglion, IMG – inferior mesenteric ganglion, SMG 
– superior mesenteric ganglion) as well as paravertebral ganglia on the way to the spinal cord. On the 
right, the vagus nerves to the nucleus tractus solitarius (NTS) of  the brainstem, and the pelvic nerves 
innervating the sacral spinal cord (Gebhart, 2000)  
  
1.5 What activates visceral afferents?  
 
Vagal and spinal afferents terminate in various levels within the gut wall and are responsible 
for the transduction of sensory information to the CNS. They are equipped with various 
receptors that respond to mechanical and chemical stimuli (Grundy, 2004). 
 
Mechanosensation  
The GI tract has a primary mechanical function, and ability to detect mechanical stimuli is 
critical for healthy function of the gut, for example in the stomach, distension is important for 
satiety and motility (Alcaino, 2017). Alterations in mechanosensation are associated with 
disorders such as constipation (Neshatian, 2015), obesity (Daly, 2011; Acosta, 2015) and the 
pathogenesis of colon cancer (Fernandez-Sanchez, 2015).   
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Mechanosensitive extrinsic afferent fibres terminate within the longitudinal and circular muscle, 
the mesentery, within enteric ganglia or close to the interstitial cells of Cajal (Lynn, 2005). 
Serosal and mesenteric afferents are activated by distortion of the mesenteric attachment, not 
the gut wall, meaning distension must be substantial in order to elicit afferent firing (Berthoud, 
2004). Muscular afferents respond to distension of the gut wall, vagal afferents exhibit 
sustained responses, whereas splanchnic afferents are quicker adapting (Blumberg, 1983; 
Janig, 1991; Blackshaw, 1987). Mucosal afferents of both vagal and splanchnic origin are not 
activated by distension or contraction of the gut wall, they are more sensitive to mechanical 
deformation of the mucosa and adapt rapidly to continuous stimuli (Lynn, 1999; Cottrel & Iggo, 
1984).   
  
The stimulus-response profiles of extrinsic afferents to mechanical stimuli depend on their 
origin, vagal afferents transduce stimuli within the physiological range, and splanchnic 
afferents mediate mostly pain (Cervero, 1994; Blackshaw, 2002). There are also afferents 
which only respond to mechanical stimuli after inflammatory insult, known as silent 
afferents/nociceptors (Feng, 2010; Gold, 2010).   
  
The identities of the mechanosensitive ion channels in the gastrointestinal tract are still elusive 
(Alcaino, 2017). The ion channel families that have so far been associated with 
mechanosensation are the degenerin/epithelial sodium channels (DEC/ENaC), the transient 
potential (TRP) channels and the acid sensing ion channel (ASIC) families (Page, 2005). 
Recently, the Piezo ion channel family was discovered (Coste, 2010), and research groups 
have described their function in gut mechanosensation (Wang, 2016). Through studies on 
sensory nerves from TRPA1-/- mice, Brierley et al found a role for TRPA1 in 
mechanosensitivity. The response to noxious colonic distension was significantly reduced 
compared to control mice, and TRPA1 agonists led to mechanical hypersensitivity, which was 
exacerbated in colitis (Brierley, 2009). TRPV1 -/- mice exhibit significantly attenuated afferent 
responses to jejunal (Rong, 2004) and bladder (Daly, 2007) distension.   
  
Chemosensation  
  
A large range of chemical mediators can directly or indirectly influence the activity of visceral 
afferent nerves (Grundy, 2004). This can occur through direct activation of ligand gated ion 
channels, and through sensitization, which involves altering the activation threshold of another 
ion channel for example bradykinin lowers the heat activation threshold of TRPV1 (Sugiura, 
2002). There is another mechanism of modulating the sensitivity to chemical stimuli, by altering 
the expression or activity of channels and receptors, for example, cholecystokinin is a 
neuropeptide that can regulate the expression of endocannabinoid receptors, in fasting state 
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the cannabinoid CB1 receptor is upregulated and after feeding, expression is lowered 
(Burdyga, 2004).   
  
In the small intestine, serosal and mesenteric afferent nerves are chemosensitive, facilitated 
by their close contact with blood vessels (Lynn, 1999; Blumberg, 1983), responding to 
circulating or locally released factors such as adenosine triphosphate (ATP), bradykinin, 
capsaicin, histamine and 5-HT (Hicks, 2002; Coldwell. 2007; Barbara, 2007). These mediators 
are released in inflammatory states, by activated mast cells, and act directly on sensory 
nerves, or indirectly by initiating release of other agents, which in turn activate the sensory 
nerves. The presence of inflammatory mediators around the nerve terminal alters the 
expression of inflammatory receptors, in a process known as sensory neuronal plasticity 
(Kirkup, 2001). During local tissue injury, there is release of chemical mediators such as ATP, 
bradykinin, and prostaglandin E2 (PGE2), substances that can activate the afferent neurons 
directly or indirectly through triggering release of algesic mediators such as histamine, 5-HT 
and nerve growth factor (NGF) (Bueno, 2002).  
  
Mechanical stimulation of the gut mucosa leads to release of serotonin (5-HT) by 
enterochromaffin cells (Bulbring, 1959; Bertrand; 2004) resulting in secretion of fluid (Cooke, 
1997) and stimulation of motility (Heredia, 2009). 5-HT receptors compose a large group of 
structurally and pharmacologically distinct families of which there is one, 5-HT3, classed as a 
ligand gated ion channel (Barnes, 1999). 5-HT3 is expressed on vagal afferent terminals 
(LealCardoso, 1993; Hillsley, 1998; Kreis, 2002) and application of 5-HT causes an increase 
in afferent firing, which is significantly attenuated by 5-HT3 antagonists (Hillsley, 1998). 5-HT3 
activation leads to increased glutamatergic transmission in the NTS of the brain (Glaum, 1992; 
Takenaka, 2011), which modulates various autonomic functions (Andresen, 1994).   
  
TRPV1 is a ligand gated ion channel activated by capsaicin, noxious heat and acid (Caterina, 
1997; Huang, 2002). It is expressed on sensory nerves that project to the trigeminal, nodose 
and dorsal root ganglia, preferentially on unmyelinated fibres (Helliwell, 1998; Michael, 1999; 
Ward, 2003), as well as in the brain (Mezey, 2000). In the gut, TRPV1 activation on sensory 
nerves causes release of peptide transmitters, which alter functions of the smooth muscle, 
vasculature and immune responses (Barthó, 2004; Mózsik, 2007). While TRPV1 plays a major 
role in exacerbating the inflammatory response in colitis, ileitis and pancreatitis (Eijelkamp, 
2007; McVey, 2001; Nathan, 2001), it is also involved in gastrointestinal pain in the context of 
functional disorders of the gut such as irritable bowel syndrome (IBS) (Akbar, 2008). TRPV1 
aids in the modification of vascular, immune and smooth muscle function of the gut (Barthó, 
2004; Mózsik, 2007), through the release of transmitters such as substance P and neurokinin 
A by neurons during periods of inflammation (Holzer, 1998). Inflammatory conditions lead to 
20  
  
recruitment of intracellular TRPV1 vesicles being translocated to the plasma membrane by 
exocytosis (Morenilla-Palao, 2004). This provides a rationale for investigation of TRPV1’s role 
in gastrointestinal dysfunction in ASD through recording of mesenteric afferent nerves of the 
jejunum, as both inflammatory (Lee, 2018) and functional (Penzol, 2019) gut disorders have 
been associated with ASD.  
  
Another member of the TRP channel family is the TRPA1 channel, which is expressed on 
primary afferent neurons which project to the trigeminal, nodose and dorsal root ganglia 
(Zhang, 2004; Kobayashi, 2005; Anand; 2008), as well as in the ENS, enterochromaffin and 
enteroendocrine cells (Penuelas, 2007; Purhonen, 2008; Nozawa, 2009). Primarily, TRPA1 
was identified as a cold temperature sensor (Story, 2003), but it is also a polymodal receptor 
sensitive to endogenous and exogenous irritants (Kang, 2010). In the GI tract, TRPA1 is 
necessary for mechano- and chemosensitivity, activation by agonists increases the response 
to mechanical stimuli (Brierley, 2009; Cattaruzza, 2010). There is evidence that this 
phenomenon occurs in the context if GI inflammation, in a rat model of colitis there is 
upregulation of TRPA1 in DRGs, increasing the visceromotor response to distension (Yang, 
2008), which was abolished in TRPA1 knockout mice (Cattaruzza, 2010). Stress is associated 
with upregulation of TRPA1 in the DRG (Yu, 2010). This is interesting in the context of ASD, 
as GI symptoms has been linked to stress (Mazurek, 2013; Fulceri, 2016; Ferguson, 2017; 
Bishop-Fitzpatrick, 2015), TRPA1 may play a role in the increased hyperalgesia.  
  
  
  
  
  
  
  
  
  
 
 
 
 
 
 
 
 
  
21  
  
  
Sensory modality  Sensory 
elements  
Stimulus   Response and function  
Mechanosensitivity 
(Low threshold – 
innocuous stimuli)   
Vagal and spinal 
sensory neurones  
Neuron 
deformation  
Modulation of  ref lex activity, 
eating behaviour, pain, 
immune functions. Crosstalk 
with ENS  
 Mechanosensitivity 
(High threshold – painful 
stimuli)   
Spinal sensory 
neurones  
Neuron 
deformation  
Modulation of  ref lex activity, 
nociception (pain), blood 
f low. Crosstalk with ENS  
Chemosensitivity    Vagal and spinal 
sensory neurones  
Acid, Short chain 
fatty acids, 
ischaemia,  
inf lammation and 
injury  
Modulation of  ref lex activity, 
nociception (pain), 
cytoprotection    
Figure 1.5: a table summarizing the sensory aspects of  visceral af ferent nerves innervating the jejunum, 
the sensory elements, the stimuli they respond to and the subsequent function activation serves. 
Adapted f rom Blackshaw et al, 2007  
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1.6 Research aims  
  
This thesis focused on the alterations in circadian rhythms and sensory signalling in the 
somatic and visceral transduction pathways in two mouse models of ASD. The objectives 
included  
  
1. Inducing the valproic acid mouse model of ASD in a C57 BL/6J background  
2. Investigating the changes in behaviour over 24 hours, as a measure of circadian 
rhythm  
3. Investigating the thermosensation of two mouse models of ASD, prenatal VPA and 
BTBR, using the Dynamic Hot and Cold plate test  
4. Determining the visceral afferent sensitivity to chemical and mechanical stimuli to 
characterise the sensory function of the gut.   
  
Hypotheses  
1. The circadian rhythm of behaviour, included sleeping and eating behaviour is altered 
in the mouse models of ASD  
2. The sensitivity to noxious thermal stimuli is reduced   
3. Afferent nerve sensitivity to mechanical distension as well as 5-HT, TRPA1 and TRPV1 
agonists is altered   
4. Afferent nerve sensitivity to inflammatory mediators including bradykinin, prostaglandin 
E2, 5-HT and histamine is altered  
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2 Materials and Methods  
2.1 Animals  
Mice used in these experiments were males of three groups, control C57 BL/6J, BTBR T+tf/J 
purchased from the Jackson Laboratory, and prenatal VPA treated mice, which were induced 
from a C57 BL/6J background. All mice were housed with littermates, and received ad libitum 
food and water, in accordance with UK Home Office regulations for animal welfare. 
Experiments were conducted while the animals were between 3 and 6 months old (adult), the 
LABORAS study first, followed by the dynamic hot/cold plate tests and the jejunum recordings.  
All animals were humanely sacrificed by cervical dislocation in accordance with UK Home 
Office regulations with Schedule 1 procedures of the UK Animals (Scientific Procedures) Act 
1986.  
  
2.2 Induction of VPA model  
  
On the two days before mating, bedding from the male cages were added to the female cages. 
Breeding pairs of C57 BL/6J background were set up, female mice were placed in the male 
stud breeding cage at approximately 7 am and taken out at approximately 4 pm (9 hours). 
They were weighed and examined, then placed back into their original cage with their cage 
mates, this was taken to be embryonic day 0 (E0). On E11, the females were weighed again 
and examined, and pregnancy was determined by weight gain and abdominal palpation. The 
mice determined to be pregnant received a single subcutaneous injection of 500 mg/kg VPA.   
  
2.3 LABORAS (Laboratory Animal Behaviour Observation Registration and Analysis 
System)  
  
Tracking information provided by LABORAS include average speed, maximum speed and 
distance travelled. Habituation was started on the two days before the test. On day 1, mice 
were habituated to the experimenter and the LABORAS cage/room. Each mouse is placed in 
a separate cage with bedding, food and water, for 15 minutes. On day 2 mice were handled 
again by the experimenter and placed the LABORAS cage/room, for 30 minutes. On test day, 
the bedding, water, food and mice were weighed, and the mice were placed into their cages 
and left for 24 hours. At the end of the testing period, the mice were weighed again, and placed 
back into their home cage. The bedding, water and food were weighed again also.  
  
Data analysis  
The LABORAS software produced an excel file containing all the data collected over the 24 
hours, which was used in this analysis. The weight change of the animals, the bedding and 
water were negligible, so were not included into analysis. The data was analysed in GraphPad 
Prism and expressed as mean +/- SEM.  
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2.4 Dynamic Hot/Cold Plate  
All animals were habituated to the test room and to the Plexiglas Ugo Basile Hot-Cold Plate 
equipment, to reduces the stress response and allows for accurate analysis.  
Day 1  Day 2  Day 3  Day 4  Day 5  
Habituation day 1  
  
Home cage is 
placed in 
Behavioural lab 
for one hour  
  
Each mouse is 
placed on the 
plate set at 30 ° C 
for 15 minutes  
Habituation day 2  
  
Home cage is 
placed in 
Behavioural 
Analysis lab for one 
hour.  
  
Each mouse is 
placed in the 
plate set at 30 ° C 
for 30 minutes  
Hot plate 
test  
  
Habituation day 3  
  
Home cage is 
placed in 
Behavioural lab for 
one hour  
  
Each mouse is 
placed in the 
plate set at 20 ° C 
for 15 minutes  
Cold plate 
test  
Figure 2.1: the schedule followed for the Dynamic Hot/Cold plate experiments. The habituation is 
conducted on days 1, 2 and 4, to reduce the stress response of  the animals on test day.   
  
Hot plate test  
The video camera was started a few seconds before the test begun. The animal was placed 
on the plate set at 30 °C and its identification and the details of the test was flashed on the 
screen. The hot plate was started, increasing the temperature to 41 °C in 1 °C/min increments. 
Once this was reached, the test was stopped, the animal placed into an interim cage, the 
camera stopped, and the video saved. The plate and surrounding areas were cleaned, before 
starting next experiment.  
  
Cold plate test  
This test was conducted in identical way as to the hot plate test, except the starting 
temperature was 20°C and declined to 1°C. As the Ugo Basile plate only allows for a total of 
999 seconds between ramp changes in temperature, the temperature decrease occurred at a 
rate of 1°C/0.8 mins.   
  
Data analysis  
The videos were analysed by the experimenter, the number of escape behaviours (jumps) 
counted at the temperature at which they occurred. Results are expressed as mean +/- SEM 
with the N values, which refer to the number of animals.   
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2.5 In vitro recording of jejunum afferent nerves  
  
After the mice were sacrificed, a midline incision of the abdomen was performed, the entire 
intestine from the duodenum to the colon was excised and harvested in carbogenated Krebs 
solution (composition, in mM: NaCl 118.4, NaHCO3 24.9, CaCl2 1.9, MgSO4 1.2, KH2PO4 1.2, 
glucose 11.7). Fine dissection of the tissue was completed to leave a 2 cm segment of jejunum 
with the mesenteric neurovascular bundle attached in the recording chamber, which was 
continuously perfused with oxygenated Krebs and kept at 35°C to prevent tissue degradation  
  
  
  
  
  
Figure 1.7: in vitro preparation to measure jejunum af ferent nerve activity and intraluminal pressure. 
Schematic diagram and picture of  the preparation. A – 2 cm segment of  jejunum, B – mesenteric 
attachment pinned to C – sylgard platform of  the organ bath, D – glass electrode with a nerve bundle 
inserted. E – the ground wire and F – the inf low of  oxygenated Krebs solution.   
  
As shown on figure 1.7, the segment was cannulated to both ends of the recording chamber 
and tied firmly, one end connected to the infusion pump to allow filling of the segment, the 
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other end connected to a pressure transducer and an outflow with a three-way tap. By closing 
the tap and turning on the perfusion pump, the segment can be filled to 50 mmHg.  
The mesenteric attachment was pinned to a sylgard-lined platform to aid dissection of the 
nerve bundle. Using a dissection microscope, the surrounding adipose tissue was removed, 
and the nerve bundle identified with fine forceps. The nerve bundle was sucked into a suction 
electrode and sealed with adipose tissue to insulate the signal. The electrode was attached to 
a Neurolog (NL 100, Digitimer Ltd, UK) and an AC amplifier (NL104). Signals were amplified 
by 10, 000 times, filtered (NL125, pass band filter) and recorded on a computer via a power 
1401 analogue to digital interface and Spike2 software (Version 7.10, Cambridge Electronic  
Design, UK). Multi-unit afferent nerve activity was quantified by a Spike processor (Digitimer 
D130) to count the number of spikes over a pre-determined threshold, which was usually set 
at twice the baseline noise level.   
  
Experimental protocols  
Control distensions  
At the start of each experiment the jejunum was distended to 50 mmHg three times, to ensure 
there were no holes or leakages and distensions were reproducible, after which the nerve 
bundle dissection was started.   
  
Altering the filling rate   
Experiments were conducted at either 600 µl/min or 200µl/min, filling to 50 mmHg at 10-minute 
intervals.   
  
Extraluminal application of pharmacological agents  
All pharmacological agents were diluted with Krebs buffer and perfused into the organ bath 
using a peristaltic pump or applied directly on the bath as a bolus.   
  
Intraluminal application of pharmacological agents  
Pharmacological agents to be applied intraluminally were diluted in Krebs and perfused 
continually into the lumen using the perfusion pump.   
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Compound  Concentration   Target   Manufacturer    
2-methyl 5- 
hydroxytryptamine   
  
(2-methyl 5-HT)  
100 µM  
 
(Keating, 2008) 
5-HT3  Tocris  
Capsaicin   1 µM  
 
(Keating, 2006) 
 
TRPV1  Tocris  
Allyl isothiocyanate 
(AITC)  
100 µM  
 
(Yu, 2014) 
 
TRPA1  Sigma  
5-hydroxytryptamine  
  
(5-HT)  
5 µM  5-HT receptors  Sigma  
  
Bradykinin   
5 µM  B1 and B2  Tocris  
Histamine  5 µM  H1  Sigma  
Prostaglandin E2  5 µM  EP2  Sigma  
Figure 1.8: a table summarizing the compounds used in the jejunum af ferent nerve recording, 
concentrations and the literature they were derived f rom. 5-HT, bradykinin, histamine and prostaglandin 
E2 were included in the inf lammatory soup as previously described by Jones et al (2005).  
  
Data analysis  
Distension results were analysed using a Spike2 script, all electrophysiological data was 
presented as change in frequency of afferent discharge in response to increasing intraluminal 
pressure or application of pharmacological agent. All data was expressed as mean +/- SEM 
and n number, which refers to number of animals.   
  
  
  
  
  
  
  
 
 
(Jones, 2005) 
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3 Results  
  
3.1.1 Prenatal VPA exposed mice show altered circadian rhythm  
  
Rodents are more active in the night-time as they are nocturnal, and all the groups studied 
showed an increase in immobility in the light phase. LABORAS defines immobility as a period 
of uninterrupted resting while the animal is in a lying or sitting position. In this analysis, the 
24hour test period is split into 4-hour intervals to show the change over time. In the dark phase 
(shaded area on figure 2), the BTBR and c57 mice exhibit a decrease in immobility as they 
become more active. The VPA mice show an increase in immobility which levels out over the 
dark phase, which may be a manifestation of altered circadian rhythm.   
  
Immobility 
 
   
  
Figure 2: The alterations in immobility (a measure for sleep) shown by C57, BTBR and VPA mice over 
24 hours, the BTBR and C57 mice show a gradual increase in immobility in the light (sleep) phase and 
a gradual decrease in the dark (wake) phase. The VPA mice show increased immobility in the light 
phase, which stays high in the dark phase. VPA mice were signif icantly more immobile than the BTBR 
mice in the 12- to 16- hour interval (P = 0.0458) and the 20- to 24- hour interval (P = 0.0068) and the 
C57 mice in the 20- to 24- hour interval (P = 0.0176). C57 n = 8; BTBR = 9, VPA = 4  
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All three strains showed normal circadian alterations of feeding, as eating count was low in the 
light phase and increased in the dark phase. The time spent eating was higher in the light 
phase, they spent longer eating a smaller amount of food, while it reduced in the dark phase 
as they ate more in a shorter time period. However, the VPA mice deviate from this trend as, 
although the pattern of eating and total amount eaten was unchanged (figure 3A and 3B)., 
there were variations in time taken to eat, as shown on figure 3C. This is interesting as the 
total time eaten is unchanged, as shown on figure 3D. In the light phase, the VPA mice took 
a significantly shorter time to eat the small amount, then in the dark phase it took them much 
longer to eat the larger amount. This may be due to differences in satiety, as the meal in the 
light phase was smaller, they ate it quickly, however a larger amount of food may take them 
longer to eat, they may have eaten in smaller bursts as they got hungry soon after they ate.   
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Figure 3: the eating behaviour of  C57, BTBR and VPA mice over 24 hours. 3A: the f requency of  eating 
behaviour over 24 hours split into 4- hour intervals. In the light phase, eating count was low in all groups, 
increasing in the 8- to 12- hour interval, peaking in the 12- to 16- hour interval, then gradually decreases. 
There was no signif icant difference between the three groups (P = 0.2648). 3B:  
the total f requency of  eating over 24 hours, there was no signif icant dif ference between the three groups 
(P = 0.3346). 3C: the amount of  time spent eating over 24 hours, split into 4-hour intervals. The C57 
and BTBR showed increased eating time in the light phase, peaking between the 4- and 8- hour interval, 
and decreased in the dark phase. VPA mice spent signif icantly decreased time eating compared to C57 
in the f irst four hours (P = 0.0060), between the 4- to 8- hour interval (P = 0.0022) and signif icantly 
increased time between the 16- and 20- hour interval (P = 0.0373). compared to the  
BTBR mice, VPA mice spent signif icantly decreased time eating between the 4- to 8- hour interval (P  
= 0.0011) and signif icantly increased time between the 16- and 20- hour interval (P = 0.0109) 3D: total 
time spent eating over 24 hours. There was no signif icant dif ference between the strains, P =  
0.0987. analysed with one-way ANOVA with Bonferroni post-test. C57 n = 8; BTBR = 9, VPA = 4.  
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3.1.2 The BTBR and VPA mice displayed significantly decreased grooming than the 
c57 mice  
  
Excessive grooming behaviour by the BTBR and VPA mice is reported extensively in the 
literature, however in this study these mice groomed significantly less than the c57 mice 
throughout the 24 hours recorded. Grooming increased initially, then gradually decreased in 
all strains, however the c57s groomed consistently higher across the 24 hours recorded. In 
terms of total grooming, BTBR mice showed significantly less grooming behaviour than c57 
mice (P = 0.0090), VPAs also groomed less, but not significantly (P = 0.1158).   
  
Grooming 
 
  
  
Figure 4: grooming behaviour exhibited by the three groups over 24 hours, there didn’t seem to be 
variations in grooming between the light and dark phases. The VPA and BTBR mice groomed 
signif icantly less compared to C57 mice over 24 hours (P = <0.0001). The BTBR mice groomed 
signif icantly less compared to C57 mice in the 8- to 12- hour interval (P = 0.0060), VPA mice groomed 
signif icantly less compared to C57 mice in the 8- to 12- hour interval (P = 0.0399). analysed with two-
way ANOVA with Bonferroni post-test. C57 n = 8; BTBR = 9, VPA = 4.  
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3.1.3 VPA mice show slightly altered circadian changes in locomotion   
  
Exploratory behaviour was measured over 24 hours in the LABORAS cages, which are placed 
on sensory platforms able to detect and score rodent movements. LABORAS specifies 
distance as the total distance travelled (in metres) by the animal throughout the test. 
Locomotion is the general activity of the animal while it is mobile, and the average speed is 
defined as the speed the animal travels in millimetres per second. As the animals explore the 
new environment, all measures of locomotion decrease in all three groups over time as they 
become habituated (figures 5A, 5B and 5C)  
This data shows the circadian alterations of activity of rodents, as they are nocturnal activity 
significantly increases in the dark phase (figure 5A), however, the VPA mice do not appear to 
show these circadian alterations as their activity decreases in the dark phase. Between the 
12- and 16- hour interval, the activity of the VPA mice is significantly lower than the BTBR 
mice (P = 0.0420). BTBR mice show almost identical circadian changes in locomotion to c57s, 
but significantly increased average speed and distance travelled. Between the 8- and 12- hour 
interval, the VPA mice show significantly decreased distance travelled (P = 0.0005) and 
average speed (P = 0.0499) compared to the BTBRs.  
The distance travelled is an interesting metric as the distance increases as the animals explore 
the new environment, decreases over time as they become habituated, this trend is also 
shown in their average speed.   
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Figure 5: changes in activity over 24 hours exhibited by the C57, BTBR and VPA mice. 5A) a graph 
showing the general locomotion of  the mice. The BTBR and C57 mice show clear circadian variations 
in locomotion, as it starts low in the light (inactive) phase and increases in the dark (active) phase. VPA 
mice show a signif icant decrease in activity in the dark phase, especially in the 12- and 16-hour interval. 
(P = 0.0085). 5B) a graph showing the distance travelled in metres, the three curves were signif icantly 
dif ferent (P=0.019). The BTBR mice travel signif icantly further than the C57 and VPA mice throughout 
the test, whereas the VPA mice travel signif icantly less than the BTBR mice between the 8- and 12- 
hour interval (P = 0.0005). 5C) A graph showing the average speed travelled over 24 hours in mm/s, 
the three curves were signif icantly dif ferent (P=0.0096). As with distance, the BTBR mice travelled 
signif icantly faster than the C57 and VPA mice, the VPA mice travelled signif icantly less than the BTBR 
mice in the 8- and 12- hour interval (P = 0.0499). C57 n = 8; BTBR = 9, VPA = 4, analysed with two -
way ANOVA with Bonferroni post-test for multiple comparisons  
  
  
  
  
  
  
A   
B   C   
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3.2 Alterations in sensitivity to thermal stimuli in BTBR and VPA mouse models of 
ASD   
  
BTBR and prenatal VPA mice exhibit significantly different responses to changes in 
temperature   
The dynamic hot plate is a method of assessing thermosensation in rodents, as described by 
Yalcin et al (2009). As the temperature increases slowly from 30°C to 41°C in 1 degree/minute 
intervals, the sensory threshold, or the point at which the animal identifies as pain and exhibits 
escape behaviour (jumps) was recorded. In this study, the BTBR mice showed significantly 
reduced sensitivity to heat, response began at a higher C57 mice (40°C vs 38°C), the number 
of escape behaviours was lower at any given temperature compared to the behaviour 
exhibited by the C57 or VPA animals (P= 0.0068; n = 6). VPA mice also started responding at 
40°C also, however the number of jumps was higher than BTBRs and by 41°C, matched that 
of the C57 mice.   
  
The dynamic cold plate works in a similar way to the dynamic hot plate, the temperature is 
decreased slowly from 20°C to 1°C (1°C/0.8min) and the point at which the animal responds 
by an escape behaviour (jumps) was again recorded. In this case, the c57s and BTBRs show 
similar responses to decreasing temperature, at around 16°C the animals start jumping, but 
rate of jumping is highest from 2°C. The VPAs show very little response to cold compared to 
the other groups, response started at 2°C and number of jumps was lower compared to c57s 
but not to a significant level (p = 0.0559).   
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Figure 6: all animals displayed escape behaviour in response to alterations in temp erature, which was 
measured as number of  jumps per degree interval. Figure 6A: the graph starts at 35°C as there was no 
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response in any of  the animals between 30-35°C. Increasing temperature caused all three groups to 
increase escape behaviour, at the top temperature of  41C, the C57 group jumped 12.5 (+/- 3.66) times, 
the VPA group 12.5 (+/- 3.07) times, whereas the BTBR group jumped signif icantly less at 4 (+/ - 2.41) 
times (BTBR vs C57 p = <0.0001; BTBR vs VPA p = 0.0003)  
Figure 6B: Decreasing temperature also resulted in jumps, which starts for the C57 and BTBR mice at 
16°C where they jump around 1 time per degree. Peak escape behaviour occurs at 1°C, the C57 group 
jump 3.17 (+/- 2.04) times, the BTBR group 3.5 (+/- 1.96) times, whereas the VPA group jumped 
signif icantly less at compared to BTBRs at 0.5 (+/- 0.5) times (p = 0.0246) and less compared to c57, 
but not signif icant (p = 0.0559). C57 n = 6; BTBR n = 6; VPA n = 4.  
Analysed with two-way ANOVA with Bonferroni post-test  
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3.3 Mechanosensitivity in BTBR mouse model of ASD   
Mechanosensitivity of the jejunum was assessed in tissue taken from BTBR and c57 control 
mice through an in vitro preparation which allowed multi-unit recording of afferent nerves, as 
previously described by Rong et al (2004). Ramp distension was performed by intraluminal 
perfusion of oxygenated Krebs buffer to a maximum pressure of 50 mmHg, in order to 
stimulate the mechanoreceptors responsive to intraluminal filling.  Two filling rates were 
chosen to assess the impact of different mechanical stimuli on the afferent response, the 
jejunum was distended at either 200 µl/min (slow) and 600 µl/min (fast). Below is a sample 
trace from control c57 tissue at 200 µl/min.  
The afferent nerve response profile to increasing intraluminal pressure to 50 mmHg was 
similar in the c57 and BTBR tissues. There was a bi-phasic response evidenced by moderate 
rise in firing concomitant with rises in pressure until approximately 20 mmHg, at which point 
afferent firing increased in a linear fashion. This is a finding reported commonly (Rong, 2004; 
Keating, 2008; Rong, 2008; Wang, 2012; Daly, 2011)  
   
  
  
Figure 7: a sample trace showing the response of  mesenteric nerve f ibres to increasing intraluminal 
pressure. The multi-unit nerve f iring corresponds to the f ield potentials captured by the electrode and 
visualised as spikes which vary in amplitudes . The f requency of  f iring is shown in the mean f iring rate 
(mean spikes per 10 seconds) which shows the biphasic nature of  nerve f iring response. The black 
arrow represents the start of  perfusion, and the blue arrow represents the opening of  the three-way tap, 
allowing the gut to empty. The mean nerve f requency shows the increase rate in spike f requency per 
10 seconds, and shows a bi-phasic response, the peak nerve response at 50mmHg.   
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3.3.1 Afferent firing and compliance is altered by rate of distension   
  
An important aspect of mechanosensitivity is neurogenic adaptation, Yang et al published an 
interesting study where they showed a faster filling rate leads to increased afferent firing, as 
the increased rate does not allow for the afferent nerves to adapt as quickly as the tissue 
stretches to accommodate the increasing volume (Yang, 2012). We also observed this 
phenomenon, in control tissue the 600 µl/min filling rate (n = 10) resulted in a higher afferent 
response, the firing rate increased by 69.66% compared to the 200 µl/min filling rate (n = 5, P 
= <0.0001). This pattern was observed in the BTBR tissue (P = 0.0017) however less 
pronounced, afferent firing increased by 51.65% (600 µl/min n = 9; 200 µl/min n = 5), as shown 
on figure 8B).  
  
We observed significantly decreased pressure-volume relationship at 600 µl/min in the c57 
tissue (figure 8C). The 200 µl/min filling rate accommodated more liquid than the 600 µl/min 
rate (P= 0.0045). Strikingly, in the BTBR tissue, the opposite is true, the 600 µl/min filling rate 
allowed a significantly increased accommodation of liquid from 5 mmHg, which suggests 
alterations in the biomechanical properties of the tissue.    
 
Figure 8: the impact of  altered f illing rates on af ferent f iring and compliance. The graphs on the left 
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correspond to C57 data and the graphs on the right correspond to BTBR data. 8A shows the distension 
response to 200 and 600 µl/min in c57 tissue, the faster rate produces a signif icantly increased af ferent 
response compared to the slower rate (P = <0.0001, 600 µl/min n = 10; 200 µl/min n = 5). This pattern 
was also observed in the BTBR tissue, in f igure 8B the faster rate produced a signif icantly increased 
response (P = 0.0017; 600 µl/min n = 9; 200 µl/min n = 5) however the dif ference was not as 
pronounced. Figure 8C shows the pressure-volume relationship of  c57 tissue, the 200 µl/min f illing rate 
led to accommodation of  more volume (P = 0.0045; 600 µl/min n = 10; 200 µl/min n = 5) Figure 8D 
shows the pressure-volume relationship of  BTBR tissue, here the increased rate led to accommodation 
of  more volume (P = <0.0001; 600 µl/min n = 9; 200 µl/min n = 5) and at 10 mmHg the volume was 
signif icantly higher at the rate of  600 µl/min (P=0.0003). Analysed with two -way ANOVA with Bonferroni 
post-test.  
  
 
 
 
 
3.3.2 There is no significant difference in afferent response to 50 mmHg distension at 
200 µl/min   
The mesenteric afferent response to intraluminal filling at a rate of 200 µl/min was not different 
between tissue from BTBR and C57 mice, figure 9C shows the two curves are almost 
overlapping (P= 0.6897; C57 n = 5; BTBR n = 5). Figure 9D illustrates the pressure-volume 
relationship which is a measure of compliance. The BTBR tissue showed a significant 
decrease in the pressure-volume relationship (P= 0056), suggesting reduced accommodation 
of volume as the pressure increased.  
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Figure 9: The f igure above shows sample traces for the C57 tissue (9A), BTBR tissue (9B), the graph 
illustrating the data collected f rom all the preparations (9C) and the pressure-volume relationship (9D).  
The slope of  the curve of  f igure 9C overlaps roughly, as there was no dif ference in f iring between the 
two groups (P= 0.6897). Peak change in f iring was 54.62 (+/- 10.33) imp/s-1 in the c57 tissue and 50.44 
(+/- 15.53) in the BTBR tissue. 9D illustrates the pressure-volume relationship during the ramp 
distensions, the BTBR tissue showed signif icantly reduced volume at the higher intraluminal pressures.  
C57 n = 5; BTBR n = 5, analysed with two-way ANOVA with Bonferroni post-test.  
 
 
 
  
3.3.3 Faster distension rate causes significantly lower afferent response in BTBR 
tissue   
  
In this study, the rate of distension was increased to 600 µl/min in order to assess the 
responses of the afferents in the BTBR and C57 tissue, and if there are any differences. As 
shown on figure 10C, the BTBR tissue exhibited significantly decreased afferent firing after 10 
mmHg compared to the C57 tissue (P= 0.0006; C57 n = 10; BTBR n = 9). We summarised 
the response profiles to distension on figures 10E and 10F, the ‘low threshold’ firing was taken 
as change in afferent firing occurring between 0 – 20 mmHg and ‘high threshold’ firing was 
taken between 20 – 50 mmHg. This gives a rough measure as to which component of the 
ramp distension profile is affected in the BTBR tissue. The high threshold firing was similar 
between the C57 and BTBR tissue (figure 10F; P = 0.6254), and the low threshold firing was 
attenuated in the BTBR tissue, although not significant (figure 10E; P = 0.1628).  
The compliance was also significantly altered, at 600 µl/min, the BTBR tissue accommodates 
significantly more volume than the C57 tissue (P = <0.0001). It is striking to see that the BTBR 
tissue can accommodate more volume, but the afferent firing is lower, this may reflect 
alterations in the function of the mechanosensitive receptors in the gut wall, changes in the 
biomechanical properties or structure of the tissue. This is compounded by the alterations in 
response depending on the rate of filling.  
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Figure 10: The f igure above shows sample traces for the C57 tissue (10A), BTBR tissue (10B), the 
graph illustrating the data collected f rom all the preparations (10C) and the pressure-volume relationship 
(10D). 10C shows the BTBR tissue exhibits a signif icantly reduced response to distension, peak change 
in f iring was 92.68 (+/- 12.80) imp/s-1 in the c57 tissue and 76.49 (+/- 15.44) in the BTBR tissue. 10D 
illustrates the pressure-volume relationship during the ramp distensions, the BTBR tissue showed 
signif icantly increased volume at the higher intraluminal pressures. C57 n = 10; BTBR n = 9, analysed 
with two-way ANOVA with Bonferroni post-test. 10E shows a comparison between the af ferent 
discharge rates between 0 – 20 mmHg (low threshold), and 10F shows the change in af ferent f iring 
between 20 – 50 mmHg (high threshold) between the C57 and BTBR tissue. The low threshold analysis  
shows a decreased response in the BTBR tissue, but not to a signif icant degree (P = 0.1628) whereas 
there was no dif ference in the high threshold analysis (P = 0.6254). Analysed with unpaired t -test.  
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3.4 Chemosensitivity in BTBR mouse model of ASD  
  
Chemosensitivity was measured by the afferent nerve response to application of various 
drugs, including 100 µM 2-methyl 5-hydroxytryptamine, 1 µM capsaicin and 100µM AITC in 
order to stimulate the 5-HT3, TRPV1 and TRPA1 receptors respectively. We also used a 
cocktail of inflammatory mediators termed ‘inflammatory soup’, consisting of 5-HT, 
prostaglandin E2, histamine and bradykinin, all at 5µM concentrations. The aim was to simulate 
an inflammatory insult to the gut and record the afferent nerve response to such stimulation.   
 
 
3.4.1 No significant difference in response to 5-HT3 agonist 2-methyl 5-HT 
  
5-HT is a neurotransmitter most abundant in the gut and modulates a wide variety of different 
processes. In the ASD literature, there has been reports of both increased and decreased 
production of 5-HT, which is then attributed to the increased rates of gastrointestinal 
dysfunction in ASD (Israelyan, 2019). We first used 100 µM 5-HT, however failed to obtain 
reproducible results so chose to use the synthetic 5-HT3 receptor agonist 2-methyl 5-HT 
instead, which did give good results. In this study, the organ bath perfusion was paused, 100 
µM 2-methyl-5HT applied as a bolus dose into the bath, left for 60 seconds and the perfusion 
was then restarted. There was no difference in response to 2-methyl 5-HT, although the 
general response was quite moderate in both C57 and BTBR tissue (P = 0.4070; C57 n = 8; 
BTBR n = 5).   
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Figure 11: this f igure consists of two sample traces, which show the af ferent response of  11A) C57 and 
11B) BTBR tissue to 100 µM 2 methyl-5-HT. On each trace there are two arrows, which represent the 
point at which the compound was added and washed out. In both cases, the responses are quite 
moderate compared to the baseline before application. 11C shows comparison of  the af ferent nerve 
response to 5-HT3 activation in c57 and BTBR tissue over 400 seconds. There is no signif icant 
dif ference between the groups in response to 2-methyl 5-HT application (P =0.4070). C57 n = 8; BTBR 
n = 5. All points are mean +/- SEM. Analysed with two-way ANOVA with Bonferroni post-test  
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3.4.2 There was a significant alteration in TRPV1 response in BTBR tissue   
  
Altered TRPV1 function has been reported in the dorsal root ganglion (DRG) neurons in an 
animal model of ASD (Han, 2016), in this study the aim was to characterise TRPV1 function 
at the primary afferent level. 1 µM capsaicin was applied extraluminally through the perfusion 
pump, the arrows on the sample traces below show when the capsaicin reached the bath 
(observed through bubbles in the organ bath). The second arrow is at the washout point, when 
fresh Krebs entered the bath (again observation of bubbles) which was changed when the 
capsaicin solution had fully perfused. In both traces, there is an initial increase in firing which 
is followed by a decrease, then another increase, which perhaps shows the activation of 
different populations of nerves. Figure 12C shows a significantly prolonged response in the 
BTBR tissue (P = <0.0001; C57 n = 5; BTBR n = 5). It takes a longer time to reach the 
desensitization stage which may mean altered function of TRPV1 at the nerve terminals.  
  
 
 
 
 
 
C 
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Figure 12: this f igure consists of two sample traces, which show the af ferent response of  12A) C57 and 
12B) BTBR tissue to 1 µM capsaicin. On each trace there are two arrows, which represent the point at 
which the compound was added and washed out. 12C shows comparison of  the af ferent nerve response 
to TRPV1 in c57 and BTBR tissue over 400 seconds. The BTBR tissue shows delayed desensitization, 
as the response is maintained past the point at which the C57 tissue desensitizes, this may suggest 
altered function or expression of  TRPV1. C57 n = 5; BTBR n = 5. All points are mean +/ - SEM. Analysed 
with two-way ANOVA with Bonferroni post-test  
  
  
  
3.4.3 There was no significant difference in response to TRPA1 activation   
  
TRPA1 is another member of the TRP family which is expressed on the primary afferent 
terminals of the jejunum (Brierley, 2009; Yu, 2009). It is activated by chemicals such as 
mustard oil and noxious cold (Jordt, 2004), and has not been evaluated in ASD models. In this 
study, 100 µM AITC was applied through the perfusion pump in the same protocol as 
described above with capsaicin. Figure 13A is a sample trace of C57 tissue, there is a 
significant increase in firing which persists for a relatively long time, which is also shown in 
13B, a sample trace of BTBR tissue.   
In this study, there was no significant differences between the two groups in afferent response 
to application of 100µM AITC (P = 0.5557; C57 n = 5; BTBR n = 5). This may suggest TRPA1 
is not relevant in the gastrointestinal dysfunction in ASD.   
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Figure 13: this f igure consists of two sample traces, which show the af ferent response of  13A) C57 and 
13B) BTBR tissue to 100 µM AITC. On each trace there are two arrows, which represent the point at 
which the compound was added and washed out. Figure 13C shows a comparison of  the af ferent nerve 
responses to TRPA1 activation in c57 and BTBR tissue over 400 seconds. There is no signif icant 
dif ference between the groups in response to AITC application (P =0.5557). C57 n = 5; BTBR n = 5. All 
points are mean +/- SEM. Analysed with two-way ANOVA with Bonferroni post-test  
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3.4.4 Application of inflammatory soup elicited a significantly increased response in 
BTBR tissue  
  
Inflammatory soup is a term describing the mediators that are often associated with 
inflammatory pain transduction. In this study, the recipe was taken from Jones et al (2005), 
including 5 μM final concentrations of bradykinin, serotonin, histamine and prostaglandin E2 to 
sensitize chemosensitive afferents. The inflammatory soup was applied intraluminally, at a 
rate of 600 µl/min, then replaced with fresh Krebs buffer to wash out. As shown in figure 14A, 
the C57 afferents responded with a peak response, returning to baseline shortly after, whereas 
in 14B the BTBR afferents show a prolonged response. 14C illustrates BTBR tissue shows 
significantly increased response to inflammatory mediators compared to C57 tissue (P =  
0.0138; C57 n = 5; BTBR n = 5).   
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Figure 14: this f igure consists of two sample traces, which show the af ferent response of  14A) C57 and 
14B) BTBR tissue to inf lammatory soup. On each trace there are two arrows, which represent the point 
at which intraluminal perfusion is started, and when it is replaced with f resh Krebs buf fer to wash out. 
Figure 14C shows a comparison of  the af ferent nerve responses to inf lammatory mediators in c57 and 
BTBR tissue over 400 seconds. BTBR tissue shows signif icantly increased response to inf lammatory 
mediators compared to C57 tissue (P=0.0138). C57 n = 5; BTBR n = 5. All points are mean +/ - SEM. 
Analysed with two-way ANOVA with Bonferroni post-test  
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4 Discussion  
 
4.1.1 Circadian alterations of sleeping and feeding in mouse models of ASD   
  
The circadian rhythm is biological timing, composed of the suprachiasmatic nuclei (SCN) of 
the hypothalamus which regulates the 24-hour rhythm of locomotion, hormones and feeding 
(Potter, 2016). In this study, the Laboras test was conducted as a non-invasive method of 
analysing the circadian rhythm of the control c57, BTBR, and prenatal VPA mice. The Laboras 
software gives many measures of activity relevant for this analysis, including locomotion, 
eating count, time spent eating and immobility.  
  
In figure 5, the VPA mice showed significantly decreased activity at certain points of the dark 
(wake) phase, while the BTBR mice had similar changes in activity as the c57 mice. This 
pattern was also observed in the immobility exhibited by the three groups, figure 2 shows VPA 
mice showed significantly increased inactivity in the dark phase compared to the BTBR and 
c57 mice, which show comparable inactivity. This could mean that circadian rhythm of activity 
is normal in the BTBR mice but altered in the VPA exposed mice.  
  
Tsujino et al also found altered circadian rhythms in VPA exposed rats, however the pattern 
is different, the locomotor activity was normal in the dark (wake) phase but higher in the light 
(sleep) phase compared to the control rats (Tsujino, 2007). Their results showed that the VPA 
exposed rats had shorter sleep times and more frequent arousal, however in this study, the 
VPA exposed mice had greater sleep times and less arousal in the dark phase. Cusmano et 
al conducted electroencephalogram (EEG) and electromyographic (EMG) recordings in VPA 
exposed rats to analyse the sleep times and time spent in non-rapid eye movement (NREM) 
and rapid eye movement (REM) in the dark and light phases. Their results showed VPA 
exposed rats spent significantly more time in wake and significantly less time in NREM sleep 
compared to controls, they also exhibited increased high frequency activity and disruptions in 
the GABAergic system which modulates sleep states (Cusmano, 2014). The discrepancies in 
finding could be due to species differences, the present study used a c57 background, 
however Tsujino et al and Cusmano et al both used Wistar and Sprague-Dawley rats 
respectively. The prenatal VPA exposure could have different effects on the circadian rhythm 
in each species. Nonetheless, the n number for VPA exposed mice was quite small, four mice 
from two litters, so a bigger n number is required before any definitive conclusions can be 
made.  
  
Tsujino et al also investigated circadian rhythm of feeding, their results show increased counts 
of feeding in the light (sleep) phase, while in this study, we found the time taken to eat was 
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altered, not the counts of eating. This is a very important distinction, as time taken to eat 
denotes feeding frequency and satiety, longer duration of meals could indicate an alteration in 
the feedback mechanism controlling satiation and fullness. This suggests altered vagal 
chemosensation and perhaps mechanosensation, however, the ex-vivo gut recordings could 
not be conducted in prenatal VPA mice due to lack of time.   
  
4.1.2 Grooming in ASD mouse models  
  
Grooming is an innate behaviour exhibited by animals and serves multiple purposes, for 
hygiene, thermoregulation and social communication, especially in the context of social 
grooming or allogrooming (Spruijt, 1992). Grooming also serves the function of de-arousal, in 
rodents grooming can occur after a period of anxiety after a stressful situation has passed 
(Kalueff, 2016).  
  
A striking finding of this study was the significantly decreased grooming presented by the 
BTBR and VPA mice. This stands in clear opposition to the vast catalogue of research 
presenting increased grooming in BTBR (Amodeo, 2014; Brodkin, 2013; Cai, 2019; Nadeem, 
2019; Amodeo, 2018, Wu, 2017) and prenatal VPA (Du, 2017; Campolongo, 2018; Mehta, 
2011; Wang, 2018) models of ASD. These studies were all conducted in an open field, or 
similar test where an animal is placed in a lightly bedded, or unbedded, box and recorded for 
10 or 20 minutes. In these tests, the VPA and BTBR mice groom significantly more than the 
control mice. Kang et al conducted a study where they used both methods, a self -grooming 
test where they recorded the animals for 10 minutes, and a LABORAS test where they 
recorded the animals for 48 hours. In the self-grooming test, the VPA mice groomed 
significantly more than control mice, however, in the LABORAS test, they found no significant 
difference in grooming time (Kang, 2015). They explained that the increased self grooming 
exhibited by VPA mice in the self-grooming tests conducted widely in the literature, may be 
novelty-induced grooming. The home cage-like environment of the LABORAS cage is more 
familiar to the mice, and decreased novelty may result in decreased stress.     
  
Individuals with ASD have reduced novelty processing or enhanced familiarity preference 
(Maes, 2011), and VPA treated rats explore a novel environment less than controls as reported 
by Schneider & Przewlocki and Olexová et al (Schneider & Przewlocki, 2005; Olexová, 2013), 
BTBR mice also exhibit novelty aversion (McTighe, 2013).  
To conclude, this evidence suggests that mouse models of ASD may exhibit novelty-induced 
grooming in self-grooming or open field tests, if these animals are tested in a home cage-like 
environment, they exhibit significantly reduced grooming compared to control mice. This may 
be due to a reduced capacity for novelty processing and rigidity and may be another example 
53  
  
of validation of these models for ASD, as fears of novelty and resistance to change is a 
symptom often associated with ASD (Kerns, 2017).  
  
4.1.3 Locomotion in ASD mouse models  
  
In this study, there were differences in locomotion exhibited by the three strains, as defined by 
counts of locomotion, distance travelled, and average speed of movement measured over 24 
hours in the LABORAS cages. The BTBR mice exhibited mild hyperactivity, as there was a 
steeper increase in distance travelled in the first 8 hours of the test, and significantly increased 
average speed. This is consistent with results reported by Faraji et al who, through an open 
field test, found BTBR mice explored significantly faster than C57 mice. They conclude this 
phenotype is a manifestation of hyperactivity, which has been reported in children with ASD 
(Faraji, 2018; Johnson, 2011). In contrast, Jasien et al found no difference in distance travelled 
in their open field test (Jasien, 2014). It is important to note the difference in methodology of 
these studies, Faraji et al conducted a 20-minute test, compared to Jasien et al, where the 
test was 10 minutes long, which is very short compared to the 24 hours of data collected in 
this study. The increase in recording time provides a more complete picture of the behaviour 
of the mice, allowing for habituation and adaptation to the environment.    
  
The VPA mice exhibited significantly increased locomotion in the first 4 hours of the LABORAS 
test, however this decreased rapidly. In general, the VPA mice exhibited decreased 
locomotion than BTBR or c57 mice, however not significantly. They travelled significantly less 
distance and average speed, compared to BTBR mice. Peralta et al also observed rats 
prenatally treated with VPA showed significantly reduced mean speed and total distance 
travelled, describing it as ‘hypokinetic’ (Peralta, 2016). However, Schneider and Przewlocki, 
found adult VPA-treated rats exhibited normal locomotion in an open field test and reduced 
exploratory behaviours such as rearing (Schneider and Przewlocki, 2005). These differences 
may not be due to methodology, as Kang et al also found no significant difference in distance 
travelled by the VPA rats in a 48-hour LABORAS test (Kang, 2015). In this study, rearing was 
normal in both BTBR and VPA mice.     
  
There are studies linking ASD to Attention Deficit Hyperactivity Disorder (ADHD), in studies of 
emotional recognition and theory of mind, Buitelaar et al found no differences between ASD 
and ADHD individuals, and Sinzig et al found a high phenotypical overlap between the two 
disorders (Sinzig, 2009; Buitelaar, 1999). In the DSM-V, there is a diagnostic category of 
ADHD comorbid with ASD (American Psychiatric Association, 2013). In the context of this 
study, the increased distance travelled and increased average speed shown by the BTBR 
mice could be evidence for hyperactivity in this strain, however further research is needed.  
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4.2 Thermosensing in ASD mouse models  
  
Most studies on thermal thresholds and sensitivity in ASD have been based on the traditional 
hot plate test, where the plate is set to a known nociceptive temperature and the animal is 
placed on it, the time taken for the animal to withdraw its paws from the hot surface is recorded. 
This is a common, reproducible test, however it does not give a wide picture of nociceptive 
thresholds, as different manifestations of sensory disruptions cannot be measured. In the 
context of ASD, this is an important field as tactile allodynia has been reported in children with 
ASD, where innocuous mechanical stimuli were considered painful and related to deficits in 
self-regulation (Silva, 2016). The dynamic hot/cold plate test was performed to investigate any 
potential changes in thermal sensitivity using a technique which allows identification of any 
changes in response to gradual changes in thermal stimuli.   
  
As shown on figure 6A, BTBRs has a significantly reduced response to the dynamic hot plate, 
as shown by delayed start to jumping, and a reduced number of jumps in total. This suggests 
that the BTBR animals have a hyposensitivity to heat. However, in figure 6B, BTBRs respond 
comparably to c57s to decreasing temperature, suggesting a normal sensitivity to cold. VPA 
mice responded in an opposite manner to the BTBRs, as they showed normal responses to 
heat, but hyposensitivity to cold. This is a striking result and could mean differences in the 
central or peripheral nociceptive pain pathway in both models. The altered temperature 
perception and response in the mouse models of ASD could be due to aberrations in function 
of any point of the sensory transduction pathway, from the afferent nerves that detect the 
stimuli, to the spinal cord where the sensory information is processed, and further up to the 
somatosensory cortex of the brain (Bokiniec, 2018). Wang et al suggest that although CNS 
processing is vital for sensory transduction, it is only as good as the information collected by 
the primary afferents. Most neurons are polymodal, they are activated by a range of stimuli. 
By conducting in vivo calcium imaging studies on anaesthetised mice and stimulating their 
paws with different temperatures, their study revealed that there are fundamental differences 
in the way hot and cold stimuli is encoded by the dorsal root ganglion (DRG) neurons. (Wang, 
2018).   
  
In the context of ASD, there is very sparse data on the function of thermosensitive afferents in 
the skin. There have been many studies finding alterations in C-tactile afferent fibres, which 
mediate low force stroking, such as hypo and hyperfunction and fewer numbers of fibres 
(Kaiser, 2016; Riquelme, 2016; Silva, 2016), however, fewer studies on Aδ or C fibres which 
mediate nociceptive signalling. Wang and Almeida et al found hyposensitivity to electrical 
stimulation of C fibres, and normal responses to stimulation of Aβ and Aδ in BTBR mice (Wang 
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and Almeida, 2016). This is significant as C fibres are important for thermal and mechanical 
nociception (Alizadeh, 2014), and is concordant with the results of this study where there was 
hyposensitivity to heat nociception in BTBR. A possible explanation of the data in this study 
might be that in the BTBR animals there is a reduction in C fibre sensitivity, which translates 
to altered thermosensitivity.   
In Han et al’s study, Shank3 -/- and Shank3+/- mice also showed reduced responses to 
spontaneous pain, as measured by reduced time spent licking paws injected with 10 µg 
capsaicin. Further, homozygous conditional knock outs of Shank3 in the peripheral nociceptive 
sensory neurons showed heat deficits that were like those observed in TRPV1 knock out mice 
(Han, 2016). Altered TRPV1 function in the somatic afferent nerves of BTBR mice may explain 
the hyposensitivity observed in study.   
  
To date, there have been no studies on cold sensitivity in VPA mice in the literature. The 
hyposensitivity to cold nociceptive stimuli is thus a novel finding. There may be alterations in 
function of afferent fibres, expression of sensory ion channels such as TRP channels or 
abnormalities in integration and processing at the level of the CNS. Alterations in the 
somatosensory and insular cortices of VPA mice is a commonly reported finding (Dendrinos, 
2011; Kataoka, 2013; Hara, 2017; Campolongo, 2018). As shown in figure 1.2, these brain 
regions are essential in the thermal transduction pathway. It is important to note that this data 
shows VPA mice exhibit normal responses to increasing temperature, the deficit only occurs 
in the decreasing temperature, which may suggest deficits specific to cold sensation. This may 
be due to altered TRPM8 or TRPA1 expression at the somatic primary afferents. There is 
clearly a need for further study in this field, as the altered thermal nociception in ASD has 
significant clinical implications.  
  
4.3 Alterations in visceral signalling in ASD models  
Sensory information from the visceral organs are conveyed through afferent nerves to the 
central nervous system. Changes in afferent signalling may be evidence of pathophysiological  
processes, in cases of visceral hypersensitivity (Mayer, 1994). Gastrointestinal disturbances 
are well characterised in ASD symptomology, however there has been little inquiry in the 
neural element of the gut-brain axis despite its influence in health and disease  
  
4.3.1 Afferent nerve response to intraluminal distension   
Different distension rates were chosen to assess the impact of altered mechanical stimuli on 
the afferent nerves, in figure 8A, the afferent firing in response to a filling rate of 600 µl/min 
was significantly higher than at 200 µl/min in control mice. This phenomenon was also 
observed by Yang et al, who found that filling rates of 500 µl/min and 1 ml/min induced higher 
afferent firing compared to 300 µl/min. They attribute it to increased neural adaptation of the 
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mechano-receptors, where the responsiveness of the afferent nerve decreases at constant 
stimuli, and faster rates correspond with increased dynamic changes in stress and strain 
(Yang, 2012). However, they ruled out any involvement of the adaptation of smooth muscle 
as they observed no difference in the stress and strain at the different rates. Multi-unit 
recordings of mesenteric nerves give a general picture of mechano-sensitivity, but also allow 
further analysis of specific field potentials (spikes) within the recordings that are identifiable 
and specific in wavelength and amplitude (Hillsley, 1998). In the context of a distension 
experiment, this allows the analysis of the relationship between stimulus and response of the 
individual fibres and classify them according to the point at which afferent activity begins, at 
low pressure (low threshold mechanoreceptors) or high pressure (high threshold 
mechanoreceptors) (Daly, 2011). There are also fibres that start firing at low pressures but 
increase in a linear pattern as the pressure increases, which have been termed wide dynamic 
range fibres (Keating, 2008). Yang et al conducted this analysis and found some fibres that 
previously did not fire at low pressures were activated when the rate was increased, and low-
threshold units behaved like wide dynamic range fibres at the higher rate. This suggests that 
there may be a temporal element to the thresholds of afferent firing.   
  
We observed that at the faster rate of 600 µl/min, the BTBR tissue displayed a significantly 
attenuated response to distension compared to the C57 tissue. This is striking as the firing 
rates are almost identical at 200 µl/min. At the 200 µl/min rate, it took approximately 138 
seconds to reach 50 mmHg, whereas at 600 µl/min it took approximately 45 seconds to reach 
the same pressure, which shows it is a more intense mechanical stimuli to the gut. The 
reduced response by the BTBR afferents may suggest attenuated response to nociceptive 
stimuli. It is interesting to regard this data alongside the TRPV1 data, as it considered a 
mechanically active ion channel (Jones, 2005), mechanical stimulation of TRPV1 appears to 
show reduced activation, whereas chemical stimulation shows prolonged sensitization of the 
receptor. In Rong et al’s study of jejunal mechanosensitivity in TRPV1-null mice, the afferent 
firing was significantly reduced in compared to control mice (Rong, 2004), noting that they 
used a distension rate of approximately 200 µl/min. In the present study, TRPV1 may be 
functionally altered in BTBR afferents, impacting the response to both sensory modalities in 
different ways. As this alteration is only clear in the increased rate of distension, it may mean 
TRPV1 function is specifically altered in pathophysiological states. This was also reported by 
Daly et al, who in their study on bladder mechanosensitivity in TRPV1-null mice, found that at 
50 µl/min, the afferent response to distension is like that of control mice (Daly, 2007). However, 
at 200 µl/min the afferent response was significantly attenuated in the TRPV1-null mice, 
through single unit analysis they found only low-threshold afferents were affected and 
concluded TRPV1 is important for nociceptive states than normal physiological function. 
These findings were very similar to those in the present study, where altered function only 
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occurred in response to increased mechanical stimulation. In-vivo, this may mean that TRPV1 
function is normal in the BTBR mice if the gut is in a healthy state, however in 
pathophysiological states its function is attenuated. This result may also be due to properties 
of the nerves, there may be increased adaptation, there may be differences in the morphology 
of the tissue which influence the biomechanical properties, for example muscle thickness or 
collagen production.  
 
We conducted further analysis of the 600 µl/min data to define whether the attenuation in 
afferent response to distension is due to the low threshold or high threshold components. 
Between 0 – 20 mmHg, the change in afferent firing was lower in the BTBR tissue, but not to 
a significant degree (figure 10E; P = 0.1628). While there was no difference in the change in 
afferent firing between 20 – 50 mmHg (figure 10F; P = 0.6254). This analysis, however, is not 
the most accurate representation of the firing rates of low and high threshold units, as it is just 
an approximation. Due to time constraints, we could not do a complete single unit analysis, 
which would be very interesting to do in further studies as it would show whether there are 
alterations in the low threshold units, of mostly vagal origin, or the high threshold units 
responsive to nociceptive stimuli projecting to the spinal cord. There is also the contribution of 
wide dynamic range units, which we couldn’t take into consideration in this study, but would 
be clear to see in single unit analysis.   
  
In this study, the measured parameters were pressure and volume, however in biomechanical 
terms, mechanoreceptors do not respond to forces acting within the lumen because the 
receptors are located further into the gut wall (Gregersen, 2013). Recently published literature 
investigating gastrointestinal mechanosensitivity have used stress and strain as parameters 
(Yang, 2015; Siri, 2019). These methods allow quantification of the impact of forces on the 
intestinal wall have on afferent nerves and would be useful to provide evidence for the 
functionality of the mechanoreceptors in heath and disease.  However, in this study, stress 
and strain were not used to measure mechanical force as it is technically difficult requiring 
extra equipment and software. There are many measurements required for this analysis, 
including length of the tissue, circumference and mid-wall radius (Gregersen, 2003). Although 
not perfect, pressure is a constant that can be measured directly in the lab with a pressure 
transducer and not dependent on calculations after the fact. This way, the experimenter can 
be sure they applied the same mechanical stimuli to each tissue, regardless of its length or 
other properties which would affect stress and strain measurements.   
  
4.3.2 Compliance of the jejunum  
Compliance is defined as the ratio between volume change and pressure change measured 
through a ramp distension (Gregersen, 2003). In figures 8C and 8D, there is first a linear phase 
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then a plateau, as the higher pressures are reached. Not only are there changes in compliance 
between tissue from the C57 and BTBR mice (figures 9D and 10D), there are also changes 
depending on rate of distension. In the c57 tissue, the 200 µl/min rate led to increased volume 
accommodation than at the 600 µl/min rate. In the BTBR tissue, the opposite is true, the faster 
rate led to the jejunum to accommodate a higher volume than the slower rate. This may be 
due to changes in the biomechanical properties of the tissue, and more in-depth analysis of 
the stress-strain properties of the BTBR tissue may provide some answers. As discussed 
above, biomechanics was beyond the scope of this study, however, this data is compelling 
and provides motivation for further studies. Changes in the viscoelasticity or composition of 
the gut could have serious effects on motility and normal function.   
  
 
4.3.3 Response to 5-HT3 activation  
 
Serotonin (5-HT) is a neurotransmitter abundant in the GI tract (Feldberg, 1953), the 
enterochromaffin cells in the gut mucosa contain the largest store of 5-HT in the body 
(Bülbring, 1959; Pan, 2000; Bertrand, 2004). As such, it is essential for many processes, 
including secretion and peristalsis through modulation of the ENS, as well as sensitizing 
afferent sensory fibres that project to the CNS (Grundy, 2008). The 5-HT receptor family is 
composed mostly of G-protein coupled receptors, except 5-HT3, which is a ligand gated ion 
channel that rapidly depolarizes neurons (Frazer, 1999). The present study aimed to 
characterise the mesenteric afferent nerve response to 5-HT stimulation, which has been 
shown to be mediated in a direct and indirect mechanism, depending on the population of 
fibres responding.  
  
Previous studies have suggested that the direct afferent response to 5HT is mediated through 
5-HT3 – expressing fibres, which generate a quick, transient burst of firing, and an indirect 
response which is mediated through 5-HT2A – expressing fibres, producing a delayed onset 
but prolonged nerve firing (Hillsley, 1998). 5-HT3 – expressing fibres are of vagal origin, as 
vagotomy abolishes the 5-HT3 mediated response (Miller, 1992), however the secondary, 
5HT2A mediated response remained (Hillsley & Grundy, 1998). As the present study was 
utilising multi-unit recording of extrinsic afferent nerves, we chose to use the synthetic 5-HT3 
agonist 2-methyl 5-HT as it gave more reproducible responses than 5-HT. There may have 
been issues with the method of administration, we put the 5-HT through the perfusion pump 
which may have been too slow, causing the nerves to be desensitized.  
  
5-HT dysregulation is implicated in ASD due to elevated blood 5-HT concentration, which is 
considered the first biomarker in ASD, reinforced by a 2014 meta-analysis by Gabriele et al 
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who concluded that peripheral elevation of 5-HT has a genetic basis, and can be used as an 
endophenotype to aid classification of ASDs (Gabriele, 2014). The BTBR model of ASD also 
exhibits hyperserotonaemia, BTBRs have decreased baseline 5-HT transporter (SERT), which 
transports 5-HT into the pre-synaptic neuron to modulate the concentrations in the synaptic 
cleft, leading to increased concentrations throughout the brain (Gould, 2014). There is also 
increased 5-HT1A activity in the hippocampus, administration of its partial agonist buspirone 
increased sociability in BTBR mice (Gould, 2011). Golubeva et al recently found dysregulated 
5-HT production in BTBRs, the availability of 5-HT was halved in the small intestine and colon, 
due to a downregulation of TPH1 and SERT genes (Golubeva, 2017). This provided a rationale 
for investigating the serotonergic system in the context of sensory nerves in the BTBR mice.   
  
As shown in figure 11, there was no significant difference in afferent nerve response to 5-HT3 
agonist 2-methyl-5-HT between tissue from the BTBR and C57 mice. However, this does not 
give a complete picture of serotonergic signalling in the mesenteric af ferent nerves, as the 
other receptor types involved were not interrogated. 5-HT is released by the enterochromaffin 
(EC) cells and secreted into the lamina propria, where it can reach neurons and activate 
specific receptors (Gershon, 2003). In our preparation, the 2-methyl-5-HT was applied into the 
organ bath, meaning it had to penetrate multiple layers of muscle and connective tissue. In 
this study, data suggesting alterations in biomechanical composition of the jejunum was 
obtained, meaning that between the C57 and BTBR tissue, there may have been variations in 
the amount of drug that reached the nerve terminal. In further studies, responses to 
intraluminal and extraluminal application could be compared to deduce which method provides 
the most reproducible responses.   
  
This study characterised only one pathway of 5-HT transmission, it is important to keep in 
mind 5-HT’s role in extrinsic sensory neurotransmission in the gut is not limited to the 5-HT3 
pathway. Hicks et al found 30% of spinal afferent fibres responsive to 5-HT also responded to 
2-methyl 5-HT (Hicks, 2002), suggesting other non-5-HT3 mediated mechanisms.   
  
  
4.3.4 Response to TRPV1 activation   
  
TRPV1 is highly expressed in nodose ganglion neurons projecting to the stomach and small 
intestine, to dorsal root ganglion neurons that travel to the colon, as well as within the enteric 
nervous system (Guo, 1999; Michael, 1999; Robinson, 2004, Kadowaki, 2004). TRPV1 
signalling in ASD was implicated by Han et al’s paper showing deletions in the Shank3 gene 
leads to diminished TRPV1 function in human DRG neurons (Han, 2016). In the present study, 
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we aimed to characterise TRPV1 function in the visceral primary afferents in a mouse model 
of ASD.   
  
In this study, 1µM concentration of capsaicin was used to assess the TRPV1 activity in BTBR 
and C57 mice, shown in figure 12. The afferent response was prolonged in the BTBR group, 
and it took longer to reach the desensitization stage. There are many possible mechanisms 
behind this altered response profile of TRPV1. Capsaicin-induced desensitization is mediated 
by the Ca2+/calmodulin pathway, as TRPV1 has two calmodulin binding domains (CaMBD), 
one in the distal C terminus (Numazaki, 2003) and one in the first ankyrin repeat domain (ARD) 
in the N terminus which also binds to ATP (Lishko, 2007). TRPV1 activation leads to an influx 
of Ca2+ ions, which bind to and activate calmodulin, further binding to ARD N terminal domain 
replacing ATP resulting in inactivation of TRPV1 and desensitization (Lishko, 2007). This 
mechanism is supported by evidence showing disrupting ATP binding by mutations in the ARD 
stopped binding of Ca2+/calmodulin and thus inhibits capsaicin induced desensitization (Lau, 
2012).   
  
The gene encoding calmodulin, CALM1, has been identified as a candidate gene for ASDs 
(Hadley, 2014) and proteomic analysis showed a decrease in calmodulin in a small population 
of children with ASD (Shen, 2017). BTBR mice exhibit a significant decrease in phosphorylated 
Ca2+/calmodulin protein kinase II in the hippocampus, which was increased by administration 
of folic acid, leading to improvements in spatial learning (Zhang, 2019). Considering this data, 
and the importance of the Ca2+/calmodulin unit in the capsaicin induced desensitization of 
TRPV1, reduced production of calmodulin could lead to the slower rate of desensitization. This 
could provide an explanation as to why the BTBR afferent nerve response to capsaicin showed 
slower desensitization of TRPV1.   
  
TRPV1 interacts with metabotropic glutamate receptors (mGluRs), which are G protein 
coupled receptors with seven transmembrane domains and classified into three groups based 
on pharmacological activity and signal transduction mechanisms (Jin, 2011; Conn, 1997). 
Group I mGluRs, especially mGluR5 is co-expressed with TRPV1 on DRG neurons and 
activation enhances TRPV1 function and increases thermal sensitivity (Hu, 2002). MGluR5 
activation results in mechanical and thermal hypersensitivity via the protein kinase C (PKC) 
signalling pathway, which can, along with protein kinase A (PKA) and Ca2+/calmodulin 
dependent protein kinase 2 (CaMK2) activate TRPV1 through its many phosphorylation sites 
(Varga, 2006; Jung, 2004). Group II/III are inhibitory receptors and are expressed on primary 
afferent neurons (Carlton, 2001) and act by inhibiting peripheral nociceptors, including TRPV1 
induced excitation (Carlton, 2009). TRPV1 activation leads to influx of Ca2+ ions which triggers 
glutamate release, the more Ca2+ is taken up by the mitochondria through the stimulus, the 
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longer the duration of glutamate release and activity at the synapse (Medvedeva, 2008). 
MGlurR2/3 has been identified as potentially analgesic, activation leads to suppressed 
sensitization in response to inflammatory mediators (Du, 2008). Inhibition of mGluR2/3 
increases activity of sensory neurons (Carlton, 2011) and pain-like behaviour (Yang, 2003) 
providing further evidence for its role in nociceptive transmission.  
  
There has been evidence of glutamate dysfunction in ASD, significantly elevated serum 
glutamate was reported in adults with ASD (Shinohe, 2006), as glutamate does not pass the 
blood-brain barrier readily (Rojas, 2014), this points to peripheral effects.  Chen et al reported 
a significantly decreased levels of mGluR2/3 protein and mRNA levels in the prenatal VPA 
model of ASD, and through administration of N-acetylcysteine which acts on the mGluR2/3, 
there was improvement of anxiety-like behaviour and increased social interaction (Chen, 
2014). There has been much work delineating the impact of mGluR5 mediated synaptic 
dysfunction in ASD, in fact, mGluR5 antagonists are in clinical trials for treating ASD patients 
as they have found to reduce the repetitive grooming behaviour in multiple animal models 
including BTBRs (Silverman, 2010), prenatal VPA (Mehta, 2011) and C58/J (Silverman, 2012).   
  
There have been no studies yet on the relationship between TRPV1 and mGluRs in 
nociceptive primary afferent signalling in ASD models, which would be a very interesting 
avenue for research. In the context of this study, dysregulation in mGluR5 activation of TRPV1 
or mGluR2/3 mediated inhibition may be behind the delayed desensitization observed following 
TRPV1 activation.  
The dynamic hot plate results show BTBR mice exhibit a hyposensitivity to nociceptive heat. 
Comparing the two sets of data, it may suggest TRPV1 function may differ depending on 
whether it is a somatic or visceral transduction pathway.   
  
4.3.5 Response to TRPA1 activation  
  
TRPA1 is another member of the TRP family of sensory receptors, and is activated by 
chemicals such as mustard oil, environmental toxins and noxious cold (Bautista, 2006; 
Bandell, 2004). The sensory disruptions experienced by individuals with ASD are well known, 
however the potential impact of TRPA1 has yet to be investigated. TRPA1 also detects 
inflammatory agents within the gut and is also expressed in intrinsic neurons as well as 
enterochromaffin cells of the gut, which suggests it has many different roles as well as sensory 
transduction (Bautista, 2013). TRPA1 has also been identified as important for 
mechanosensitivity, as intra-colonic administration of mustard oil in neonatal mice increases 
expression of TRPA1 in the DRG, which in turn leads to hypersensitivity in adulthood without 
the introduction of inflammation (Christianson, 2010).   
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The results of TRPA1 activation in this study show no significant difference between the c57 
and BTBR mice, as shown in figure 13. This suggests there is no difference in TRPA1 function 
between the two strains, as the curves were almost over-lapping. It is important to note that 
we only used one concentration of AITC, and research has shown AITC is able to activate 
TRPV1 (Alpizar, 2014). Future studies should include dose response experiments using a 
more specific agonist of TRPA1.  
 
It is interesting to compare these results to the response to the dynamic cold plate as TRPA1 
mediates cold sensitivity (Miyake, 2016). As there is no difference in either case, it may 
suggest that TRPA1 may not be involved in sensory dysfunction in BTBR mice. The cold 
hyposensitivity shown by VPA mice suggests that there may be abnormalities in TRPA1 
function in that model, further study could provide interesting results.   
  
However, in this study, desensitization of TRPA1 appeared to take much longer to occur than 
TRPV1 desensitization, and the experimental design did not take this into account. TRPA1 
also undergoes the same Ca2+ mediated inactivation as TRPV1, through the Ca2+/calmodulin 
complex (Hasan, 2017). Further studies could include longer wash-out times and show the 
rate of deactivation of TRPA1 in the BTBR and C57 tissue, and whether this coincides with 
the delayed desensitization observed in TRPV1. This could be taken further into molecular 
studies of calmodulin and its interactions with TRPA1 and TRPV1, to prove whether it is this 
mechanism that is perturbed in the BTBR mice.   
 
  
4.3.6 Response to intraluminal application of inflammatory soup   
  
After studying the functions of 5HT and TRP channels in the BTBR model of ASD, we decided 
to investigate the effect of a localised inflammatory insult on the gut. By applying an  
‘inflammatory soup’ a cocktail of mediators composed of bradykinin, prostaglandin E2 (PGE2), 
histamine and serotonin, as described by Jones and colleagues (Jones, 2005). The rationale 
for these experiments was to assess the nerve activation triggered by these mediators, which 
would give a measure of the inflammatory state of the gut in the control c57 and BTBR mice. 
The afferent nerve recording thus gives a bigger picture of the inflammatory response as 
analysing the expression of certain receptors using molecular mechanisms does not reflect 
the function of these receptors.   
  
In this study, the BTBR tissue showed a significantly increased response to intraluminal 
application of inflammatory soup than the c57 tissue (figure 14). This may show that there may 
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be an increased presence of inflammatory mediators in the gut lumen, resulting in increased 
afferent sensory transduction potentially leading to increased visceral pain. This data supports 
the literature describing enhanced systemic inflammation (Wang, 2019), and increased 
expression of inflammatory cytokines (Cristiano, 2018) in the BTBR model of ASD.   
The inflamed state of the gut in the BTBR tissue could have a wide variety of effects, in the 
structure and function of the gastrointestinal system. The enteric nervous system is organized 
into the submucosal and myenteric plexuses, and abnormalities in neuronal morphology and 
survival have been reported in IBD (Geboes, 1998). This has also been described in the colon 
of BTBR mice, Golubeva et al found the myenteric plexus showed a reduced spatial density 
and increased intra-ganglionic space, there was a 50% reduction in inhibitory motor neurons 
and total myenteric neurons (Golubeva, 2017). They deduced this may be due to abnormal 
development of excitatory and inhibitory neurons in BTBR mice, however, it also could be due 
to neuronal loss due to inflammation. In a rat model of experimental colitis induced by 
intrarectal application of dinitrobenzene sulfonic acid (DNBS), Sanovic et al found significant 
neuronal loss in the myenteric plexus, 50% reduction of neuronal number in six days (Sanovic, 
1999). Losses of myenteric neurons have also been described in models of acute colitis in 
mice and guinea pigs (Boyer, 2005; Linden, 2005).  
  
These changes in gut innervation impacts on motor function, models of colitis show reductions 
in propulsive motility and migrating motor complexes which are responsible for movements of 
faecal pellets (Hofma, 2018). There are also changes in mucosal barrier function in IBD, 
increased paracellular permeability and tight junction protein abnormalities have been shown 
in studies (Söderholm, 1999; Salim, 2010). Golubeva et al’s study also described delayed 
intestinal transit and reduced velocity of oral to anal propulsion in the BTBR mice, as well as 
increased epithelial permeability of the distal ileum and colon (Golubeva, 2017). This evidence 
adds to the theory of impaired gastrointestinal structure and function due to increased 
inflammation in a model of ASD, as well as the link between IBD and human ASD (Lee, 2018).  
   
Importantly, these impairments of the colon have effects on the small intestine, there is 
literature concluding abnormalities in the structure and function of the small intestine in cases 
of IBD and IBS. Nutrient and fluid malabsorption in the jejunum in humans (Soule, 1984) and 
various animal models (Empey, 1993; Pantzar, 1994), changes in permeability (Buning, 2012) 
and dysmotility (Rao, 1987). In this study, the inflammatory response of mesenteric afferents 
of the jejunum was investigated, and the data shows there may be increased inflammation in 
tissue from BTBR mice. If BTBR mice exhibit symptoms like those in IBD, afferent responses 
to inflammatory mediators may be enhanced in the colon. This may be another avenue of 
research which is worth following up on, this study provided a small window into 
gastrointestinal health in BTBR mice.   
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An increase in response of the sensory nerves to inflammatory mediators could mean an 
upregulation in expression or sensitization of the receptors, which functionally result in visceral 
pain. In this study, responses to capsaicin and inflammatory soup application were both 
increased in BTBR tissue, which could be linked as inflammatory mediators sensitize TRPV1 
and reduce its activation thresholds (Shin, 2002; Moriyama, 2005)  
  
  
5 Conclusion  
  
This study was designed to be a general outlook on the circadian and sensory alterations 
that are found in ASD, to identify any research avenues that could be explored more closely 
in subsequent studies and published in the future. It means that we were not able to identify 
a mechanism causing the differences identified, however this may not have been achievable 
in a one-year masters project. The jejunum was chosen due to vagal afferent input and ease 
of identification and recording of nerves. Also, following the 3Rs guidance set by the Home 
Office for animal research, the colon tissue harvested from the mice in this study was used 
by another masters student in our lab. However, in the context of gut dysfunction in ASD, the 
most common symptoms are chronic constipation and diarrhoea (Wasilewski, 2015) which 
manifest from the colon. Colon recordings would be the next step to complete the full picture 
of gastrointestinal health in the BTBR mice. In this study, the focus was kept on the neural 
element of the gut-brain axis, however it is important to keep in mind the myriad of functions 
and roles the microbiota plays in health and disease.   
  
Limitations of the study  
  
This study contained limitations, the most prominent is the time restraints. With more time, 
further experiments could be conducted to elucidate the mechanisms behind the findings. We 
were also unable to conduct the gut recording experiments in the prenatal VPA mice, there is 
significant evidence in the literature describing GI alterations in this mouse model. Further 
studies could provide interesting evidence towards this hypothesis. The n numbers were also 
small, in some experiments there were 5 of each strain, which is not a representative figure. 
This was especially evident in the prenatal VPA n numbers, which were very small, however 
this was unavoidable as we had to induce the model in-house and due to the time constraints, 
it was difficult to generate a robust n number. Also, there is the contribution of the litter effect, 
where animals from the same litter exhibit more similarities than animals from different litters, 
in the cases of maternal treatment such as prenatal administration of VPA, the n number refers 
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to the number of litters not individual mice (Lazic, 2013). Thus, the n number of prenatal VPA 
is two, with four individual mice, which is very underpowered.   
  
Future directions  
  
This study identified many potential avenues of research. Further studies in the prenatal VPA 
mouse model of ASD could provide many interesting insights, especially in the gut recordings 
as due to time limitations we could not complete those experiments in this study. The dynamic 
hot/cold plate showed the alterations in thermal signalling in both the VPA and BTBR mice, 
further studies could include direct recordings of the cutaneous afferent nerves in response to 
both thermal stimuli and other agonists of the TRP channels expressed in those terminals. 
The BTBR experiments provided many striking findings in this study, all of which could be 
taken further to find the causative mechanisms such as biomechanical alterations of the gut, 
altered afferent response to mechanical stimuli, application of capsaicin and inflammatory 
soup. Molecular studies and proteomics could add to the understanding behind the function 
of TRPV1 in BTBR mice. The inflammatory soup experiments were conducted as a general 
look into the response to inflammatory mediators, pharmacological experiments including 
individual mediators could show which pathway is altered in the gut of BTBR mice. Afferent 
nerve recordings from the colon and bladder could be conducted to complete the story of 
visceral sensation in this model, compiling evidence for a future publication.   
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